Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Typ-2-Diabetes und Adipositas Klimawandel und Gesundheit Neues aus dem Markt COVID-19 Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende
Erweiterte Suche
Anmelden
nach oben
Erschienen in:
Koexistenz von Depression, Angst, traumatischem Stress und körperlicher Krankheit – allgemeine Positionen Kapitel lesen Erstes Kapitel lesen

2022 | OriginalPaper | Buchkapitel

2. Kardiovaskuläre Erkrankungen

verfasst von : Hans-Peter Kapfhammer

Erschienen in: Depression, Angst, traumatischer Stress und internistische Erkrankungen

Verlag: Springer Berlin Heidelberg

Einloggen, um Zugang zu erhalten

Zusammenfassung

Das Thema der affektiven Komorbidität wird für folgende kardiovaskuläre Krankheiten skizziert: Koronare Herzkrankheit, Herzinsuffizienz, akute Stress-Kardiomyopathie (Takotsubo-Syndrom), arterielle Hypertonie, kardiale Arrhythmien, kardiologische und herzchirurgische Interventionen. Epidemiologische Studien belegen, dass vorbestehende affektive und Stress-bezogene Störungen das Inzidenzrisiko einer kardiovaskulären Krankheit erhöhen. Umgekehrt ist eine kardiovaskuläre Krankheit mit einem erhöhten Inzidenzrisiko von affektiven und Stress-bezogenen Störungen im Krankheitsverlauf assoziiert. Hiermit gehen eine erhöhte Morbidität und Mortalität sowie eine ungünstigere Lebensqualität einher. Vorbestehende affektive und Stress-bezogene Störungen vermitteln spezielle kardiometabolische Krankheitsrisiken sowohl auf einer systemisch-biologischen Ebene als auch auf einer Verhaltensebene. Langzeiteffekte in der Entwicklung zur klinischen Manifestation und im Verlauf sind von Akuteffekten zu unterscheiden, die zu kritischen kardialen Ereignissen führen. Psychotherapeutische und psychopharmakologische Ansätze weisen auf differentielle, häufig aber auch auf inkonsistente Effekte in der Behandlung koexistenter depressiver, Angst- und posttraumatischer Störungen hin. Trotz ermutigender Hinweise bestehen noch keine klaren empirischen Belege dafür, dass eine wirksame psychotherapeutische oder psychopharmakologische Behandlung dieser koexistenten psychischen Störungen auch schon den Verlauf des biologischen kardiovaskulären Krankheitsgeschehens entscheidend beeinflusst.
Literatur
AbuRuz ME (2018) Anxiety and depression predicted quality of life among patients with heart failure. J Multidiscip Healthc 11:367–373CrossRef
AbuRuz ME (2019) Pre-operative depression predicted longer hospital length of stay among patients undergoing coronary artery bypass graft surgery. Risk Manag Healthc Policy 12:75–83CrossRef
Agarwal S, Presciutti A, Cornelius T et al (2019) Cardiac arrest and subsequent hospitalization-induced posttraumatic stress is associated with 1-year risk of major adverse cardiovascular events and all-cause mortality. Crit Care Med 47:e502–e505CrossRef
Agorastos A, Lederbogen F, Otte C (2015) Behandlung der Depression bei koronarer Herzerkrankung. Nervenarzt 86:375–387CrossRef
Ahmadi N, Hajsadeghi F, Mirshkarlo HB et al (2011) Post-traumatic stress disorder, coronary atherosclerosis, and mortality. Am J Cardiol 108:29–33CrossRef
Akosile W, Colquhoun D, Young R, Lawford B, Voisey J (2018) The association between post-traumatic stress disorder and coronary artery disease: a meta-analysis. Australas Psychiatry 26:524–530CrossRef
Al Khathami AD, Alamin MA, Alqahtani AM et al (2017) Depression and anxiety among hypertensive and diabetic primary health care patients. Could patientsʼ perception of their diseases control be used as a screening tool? Saudi Med J 38:621–628CrossRef
Albus C, Beutel ME, Deter HC et al (2011) A stepwise psychotherapy intervention for reducing risk in coronary artery disease (spirr-cad) –rationale and design of a multicenter, randomized trial in depressed patients with cad. J Psychosom Res 71:215–222CrossRef
Albus C, Herrmann-Lingen C, Jensen K et al (2019a) Additional effects of psychological interventions on subjective and objective outcomes compared with exercise-based cardiac rehabilitation alone in patients with cardiovascular disease: a systematic review and meta-analysis. Eur J Prev Cardiol 26:1035–1049CrossRef
Alexopoulos GS (2006) The vascular depression hypothesis: 10 years later. Biol Psychiatry 60:1304–1305CrossRef
Alhurani AS, Dekker RL, Abed MA et al (2015) The association of co-morbid symptoms of depression and anxiety with all cause mortality and cardiac rehospitalization in patients with heart failure. Psychosomatics 56:371–380CrossRef
Al-Qezweny MN, Utens EM, Dulfer K et al (2016) The association between type D personality, and depression and anxiety ten years after PCI. Neth Hear J 24:538–543CrossRef
Amadio P, Colombo GI, Tarantino E et al (2017) BDNFVal66met polymorphism: a potential bridge between depression and thrombosis. Eur Heart J 38:1426–1435
Amiaz R, Asher E, Rozen G et al (2016) Do implantable cardioverter defibrillators contribute to new depression or anxiety symptoms? A retrospective study. Int J Psychiatry Clin Pract 20:101–105CrossRef
Amiaz R, Asher E, Rozen G et al (2017) Reduction in depressive symptoms in primary prevention ICD scheduled patients – one-year prospective study. Gen Hosp Psychiatry 48:37–41CrossRef
Andonian C, Beckmann J, Biber S et al (2018) Current research status on the psychological situation of adults with congenital heart disease. Cardiovasc Diagn Ther 8:799–804CrossRef
Andreazza AC, Gildengers A, Rajji TK et al (2015) Oxidative stress in older patients with bipolar disorder. Am J Geriatr Psychiatry 23:314–319CrossRef
Angermann CE, Ertl G (2018) Depression, anxiety, and cognitive impairment: comorbid mental health disorders in heart failure. Curr Heart Fail Rep 15:398–410CrossRef
Angermann CE, Störk S, Gelbrich G et al (2012) Mode of action and effects of standardized collaborative disease management on mortality and morbidity in patients with systolic heart failure: the Interdisciplinary Network for Heart Failure (INH) study. Circ Heart Fail 5:25–35CrossRef
Angermann CE, Gelbrich G, Störk S et al (2016) Effect of escitalopram on all-cause mortality and hospitalization in patients with heart failure and depression: the MOOD-HF randomized clinical trial. JAMA 315:2683–2693CrossRef
Appels A (1997) Exhausted subjects, exhausted systems. Acta Physiol Scand Suppl 640:153–154
Balint EM, Boseva P, Schury K et al (2016) High prevalence of posttraumatic stress in patients with primary hypertension. Gen Hosp Psychiatry 38:53–58CrossRef
Balog P, Konkolÿ Thege B (2019) The role of vital exhaustion in predicting the recurrence of vascular events: a longitudinal study. Int J Clin Health Psychol 19:75–79CrossRef
Balog P, Falger PRJ, Szabó G et al (2017) Are vital exhaustion and depression independent risk factors for cardiovascular disease morbidity? Health Psychol 36:740–748CrossRef
Barber S, Hickson DA, Kawachi I et al (2016) Double-jeopardy: the joint impact of neighborhood disadvantage and low social cohesion on cumulative risk of disease among African American men and women in the Jackson Heart Study. Soc Sci Med 153:107–115CrossRef
Barth J, Schumacher M, Herrmann-Lingen C (2004) Depression as a risk factor for mortality in patients with coronary heart disease: a meta-analysis. Psychosom Med 66:802–813CrossRef
Batelaan NM, Seldenrijk A, Bot M et al (2016) Anxiety and new onset of cardiovascular disease: critical review and meta-analysis. Br J Psychiatry 208:223–231CrossRef
Baumeister H, Hutter N, Bengel J (2011) Psychological and pharmacological interventions for depression in patients with coronary artery disease. Cochrane Database Syst Rev 9:CD008012
Baumgartner C, Fan D, Fang MC, et al. (2017) Anxiety, depression, and adverse clinical outcomes in patients with atrial fibrillation starting warfarin: cardiovascular research network WAVE study. J Am Heart Assoc. 2018 Apr 14; 7(8). pii: e007814. https://​doi.​org/​10.​1161/​JAHA.​117.​007814
Beach SR, Kostis WJ, Celano CM et al (2014) Meta-analysis of selective serotonin reuptake inhibitor-associated QTc prolongation. J Clin Psychiatry 75:e441–e449CrossRef
Bekke-Hansen S, Trockel M, Burg MM, Taylor CB (2012) Depressive symptom dimensions and cardiac prognosis following myocardial infarction: results from the ENRICHD clinical trial. Psychol Med 42:51–60CrossRef
Bell CN, Thorpe RJ Jr, Bowie JV, LaVeist TA (2018) Race disparities in cardiovascular disease risk factors within socioeconomic status strata. Ann Epidemiol 28:147–152CrossRef
Benderly M, Kalter-Leibovici O, Weitzman D et al (2019) Depression and anxiety are associated with high health care utilization and mortality among adults with congenital heart disease. Int J Cardiol 276:81–86CrossRef
Benjamin EJ, Virani SS, Callaway CW et al (2018) Heart disease and stroke statistics— 2018 Update. A report from the American Heart Association. Circulation 137:e67–e492CrossRef
Benkert O, Hippius H (2021) Kompendium der psychiatrischen Pharmakotherapie, 13. Aufl. Springer, BerlinCrossRef
Berg SK, Rasmussen TB, Mols RE et al (2019) Both mental and physical health predicts one year mortality and readmissions in patients with implantable cardioverter defibrillators: findings from the national DenHeart study. Eur J Cardiovasc Nurs 18:96–105CrossRef
Berkman LF, Blumenthal J, Burg M et al (2003) Effects of treating depression and low perceived social support on clinical events after myocardial infarction: the Enhancing Recovery in Coronary Heart Disease Patients (ENRICHD) randomized trial. JAMA 289:3106–3116CrossRef
Berman NC, Wheaton MG, McGrath P, Abramowitz JS (2010) Predicting anxiety: the role of experiential avoidance and anxiety sensitivity. J Anxiety Disord 24:109–113CrossRef
Bhatnagar A (2017) Environmental determinants of cardiovascular disease. Circ Res 121:162–180CrossRef
Bianchi R, Schonfeld IS, Laurent E (2017) On the overlap of vital exhaustion and depression. Eur Psychiatry 44:161–163CrossRef
Birk JL, Cornelius T, Edmondson D, Schwartz JE (2019) Duration of perseverative thinking as related to perceived stress and blood pressure: an ambulatory monitoring study. Psychosom Med 81:603–611CrossRef
Blumenthal JA, Babyak MA, OʼConnor C et al (2012a) Effects of exercise training on depressive symptoms in patients with chronic heart failure: the HF-ACTION randomized trial. JAMA 308:465–474CrossRef
Blumenthal JA, Sherwood A, Babyak MA et al (2012b) Exercise and pharmacological treatment of depressive symptoms in patients with coronary heart disease: results from the UPBEAT (Understanding the Prognostic Benefits of Exercise and Antidepressant Therapy) study. J Am Coll Cardiol 60:1053–1063CrossRef
Blumenthal JA, Zhu Y, Koch GG et al (2019) The modifying effects of social support on psychological outcomes in patients with heart failure. Health Psychol 38:502–508CrossRef
Bomhof-Roordink H, Seldenrijk A, van Hout HPJ et al (2015) Associations between life stress and subclinical cardiovascular disease are partly mediated by depressive and anxiety symptoms. J Psychosom Res 78:332–339CrossRef
Boscarino JA (2008) A prospective study of PTSD and early-age heart disease mortality among Vietnam veterans: implications for surveillance and prevention. Psychosom Med 70:668–676CrossRef
Bradley SM, Rumsfeld JS (2015) Depression and cardiovascular disease. Trends Cardiovasc Med pii: S1050–1738(15)00039
Brandsaeter B, Atar D, Agewall S et al (2011) Gender differences among Norwegian patients with heart failure. Int J Cardiol 146:354–358CrossRef
Braun J, Müller-Wieland D, Renz-Polster H, Krautzig S (2018) Basislehrbuch Innere Medizin, 6. Aufl. Elsevier, Urban & Fischer, München
Bremner JD, Campanella C, Khan Z et al (2018) Brain correlates of mental stress-induced myocardial ischemia. Psychosom Med 80:515–525CrossRef
Bremner JD, Campanella C, Khan Z et al (2019) Brain mechanisms of stress and depression in coronary artery disease. J Psychiatr Res 109:76–88CrossRef
Brudey C, Park J, Wiaderkiewicz J et al (2015) Autonomic and inflammatory consequences of posttraumatic stress disorder and the link to cardiovascular disease. Am J Physiol Regul Integr Comp Physiol 309:R315–R321CrossRef
Brydges CR, Bhattacharyya S, Dehkordi SM et al; Mood Disorders Precision Medicine Consortium (2022) Metabolomic and inflammatory signatures of symptom dimensions in major depression. Brain Behav Immun 102:42–52
Bucciarelli V, Caterino AL, Biancho F et al (2020) Depression and cardiovascular disease: the deep blue sea of womenʼs heart. Trends Cardiovasc Med 30:170–176CrossRef
Burg MM (2018) Psychological treatment of cardiac patients. Clinical health psychological series. American Psychological Association, Washington, DC
Burg MM, Martens EJ, Collins D, Soufer R (2011) Depression predicts elevated endothelin-1 in patients with coronary artery disease. Psychosom Med 73:2–6CrossRef
Burg MM, Brandt C, Buta E, Schwartz J et al (2017) Risk for incident hypertension associated with posttraumatic stress disorder in military veterans and the effect of posttraumatic stress disorder treatment. Psychosom Med 79:181–188CrossRef
Caldirola D, Schruers KR, Nardi AE et al (2016) Is there cardiac risk in panic disorder? An updated systematic review. J Affect Disord 194:38–49CrossRef
Carney RM, Freedland KE (2008) Depression in patients with coronary heart disease. Am J Med 121:S20–S27CrossRef
Carney RM, Freedland KE (2009a) Treatment-resistant depression and sudden cardiac death. J Am Coll Cardiol 54:958–959CrossRef
Carney RM, Freedland KE (2009b) Treatment-resistant depression and mortality after acute coronary syndrome. Am J Psychiatry 166:410–417CrossRef
Carney RM, Freedland KE (2012) Are somatic symptoms of depression better predictors of cardiac events than cognitive symptoms in coronary heart disease? Psychosom Med 74:33–38CrossRef
Carney RM, Freedland KE (2017) Depression and coronary heart disease. Nat Rev Cardiol 14:145–155CrossRef
Carney RM, Blumenthal JA, Freedland KE et al (2004) Depression and late mortality after myocardial infarction in the Enhancing Recovery in Coronary Heart Disease (ENRICHD) study. Psychosom Med 66:466–474CrossRef
Carney RM, Freedland KE, Rubin EH et al (2009) Omega-3 augmentation of sertraline in treatment of depression in patients with coronary heart disease: a randomized controlled trial. JAMA 302:1651–1657CrossRef
Case SM, Sawhney M, Stewart JC (2018) Atypical depression and double depression predict new-onset cardiovascular disease in U.S. adults. Depress Anxiety 35:10–17CrossRef
Celano CM, Suarez L, Mastromauro C, Januzzi JL, Huffman JC (2013) Feasibility and utility of screening for depression and anxiety disorders in patients with cardiovascular disease. Circ Cardiovasc Qual Outcomes 6:498–504CrossRef
Celano CM, Millstein RA, Bedoya CA et al (2015) Association between anxiety and mortality in patients with coronary artery disease: a meta-analysis. Am Heart J 170:1105–1115CrossRef
Celano CM, Villegas AC, Albanese AM et al (2018) Depression and anxiety in heart failure: a review. Harvard Rev Psychiatry 26:175–184CrossRef
Chang L, Liu N (2017) The safety, efficacy, and tolerability of pharmacological treatment of depression in patients with cardiovascular disease: a look at antidepressants and integrative approaches. Heart Mind 1:8–16
Cheng F, Lin P, Wang Y et al (2018) Type D personality and coronary atherosclerotic plaque vulnerability: the potential mediating effect of health behavior. J Psychosom Res 108:54–60CrossRef
Chialà O, Vellone E, Klompstra L et al (2018) Relationships between exercise capacity and anxiety, depression, and cognition in patients with heart failure. Heart Lung 47:465–470CrossRef
Chida Y, Steptoe A (2009) The association of anger and hostility with future coronary heart disease: a meta-analytic review of prospective evidence. J Am Coll Cardiol 53:936–946CrossRef
Citro R, Radano I, Bellino M et al (2022) Epidemiology, pathogenesis, and clinical course of takotsubo syndrome. Heart Fail Clin 18:125–137CrossRef
Clark AM, DesMeules M, Luo W et al (2009) Socioeconomic status and cardiovascular disease: risks and implications for care. Nat Rev Cardiol 6:712–722CrossRef
Cohen BE, Marmar C, Ren L et al (2009a) Association of cardiovascular risk factors with mental health diagnoses in Iraq and Afghanistan war veterans using VA health care. JAMA 302:489–492CrossRef
Cohen BE, Marmar CR, Neylan TC (2009b) Posttraumatic stress disorder and health-related quality of life in patients with coronary heart disease: findings from the Heart and Soul Study. Arch Gen Psychiatry 66:1214–1220CrossRef
Cohen BE, Edmondson D, Kronish IM (2015) State of the art review: depression, stress, anxiety, and cardiovascular dsease. Am J Hypertens 28:1295–1302CrossRef
Cohen R, Bavishi C, Haider S et al (2017) Meta-analysis of relation of vital exhaustion to cardiovascular disease events. Am J Cardiol 119:1211–1216CrossRef
Corbineau S, Breton M, Mialet-Perez J, Costemale-Lacoste JF (2017) Major depression and heart failure: interest of monoamine oxidase inhibitors. Int J Cardiol 247:1–6CrossRef
Correll CU, Solmi M, Veronese N et al (2017) Prevalence, incidence and mortality from cardiovascular disease in patients with pooled and specific severe mental illness: a large-scale meta-analysis of 3,211,768 patients and 113,383,368 controls. World Psychiatry 16:163–180CrossRef
Corrigan FE, Kimmel MC, Jayaram G (2011) Four cases of takotsubo cardiomyopathy linked with exacerbations of psychiatric illness. Innov Clin Neurosci 8:50–53
Cosci F (2012) Assessment of personality in psychosomatic medicine: current concepts. Adv Psychosom Med 32:133–159CrossRef
Cotter G, Milo-Cotter O, Rubinstein D, Shemesh E (2006) Posttraumatic stress disorder: a missed link between psychiatric and cardiovascular morbidity? CNS Spectr 11:129–136CrossRef
Cowan MJ, Freedland KE, Burg MM et al (2008) Predictors of treatment response for depression and inadequate social support – the ENRICHD randomized controlled trial. Psychother Psychosom 77:27–37CrossRef
Critchley HD, Taggart P, Sutton PM et al (2004) Mental stress and sudden cardiac death: asymmetric midbrain activity as a linking mechanism. Brain 128:75–85CrossRef
Cserép Z, Balog P, Székely J et al (2010) Psychosocial factors and major adverse cardiac and cerebrovascular events after cardiac surgery. Interact Cardiovasc Thorac Surg 11:567–572CrossRef
Cuijpers P, Smit F (2002) Excess mortality in depression: a meta-analysis of community studies. J Affect Disord 72:227–236CrossRef
Daskalopoulou M, George J, Walters K et al (2016) Depression as a risk factor for the initial presentation of twelve cardiac, cerebrovascular, and peripheral arterial diseases: data linkage study of 1.9 million women and men. PLoS One 11:e0153838
Davidson KW, Bigger JT, Burg MM et al (2013) Centralized, stepped, patient preference-based treatment for patients with post-acute coronary syndrome depression: CODIACS vanguard randomized controlled trial. JAMA Intern Med 173:997–1004CrossRef
Davies SJ, Allgulander C (2013) Anxiety and cardiovascular disease. Mod Trends Pharmacopsychiatry 29:85–97CrossRef
Dawson DK (2018) Acute stress-induced (takotsubo) cardiomyopathy. Heart 104:96–102CrossRef
de Hert M, Detraux J, Vancampfort D (2018) The intriguing relationship between coronary heart disease and mental disorder. Dialogues Clin Neurosci 20:31–39CrossRef
de Jonge P, Ormel J, van den Brink RH et al (2006) Symptom dimensions of depression following myocardial infarction and their relationship with somatic health status and cardiovascular prognosis. Am J Psychiatry 163:138–144CrossRef
de Miranda Azevedo R, Roest AM, Hoen PW, de Jonge P (2014) Cognitive/affective and somatic/affective symptoms of depression in patients with heart disease and their association with cardiovascular prognosis: a meta-analysis. Psychol Med 44:2689–2703CrossRef
Deng LX, Khan AM, Drajpuch D et al (2016) Prevalence and correlates of post-traumatic stress disorder in adults with congenital heart disease. Am J Cardiol 117:853–857CrossRef
Denollet J, Pedersen SS (2009) Anger, depression, and anxiety in cardiac patients: the complexity of individual differences in psychological risk. J Am Coll Cardiol 53:947–949CrossRef
Deshmukh A, Kumar G, Pant S et al (2012) Prevalence of Takotsubo cardiomyopathy in the United States. Am Heart J 164:66–71CrossRef
Dickens CM, McGowan L, Percival C et al (2004) Lack of a close confidant, but not depression, predicts further cardiac events after myocardial infarction. Heart 90:518–522CrossRef
Dickens CM, McGowan L, Percival C et al (2008) New onset depression following myocardial infarction predicts cardiac mortality. Psychosom Med 70:450–455CrossRef
Divens LL, Chatmon BN (2019) Cardiovascular disease management in minority women: special considerations. Crit Care Nurs Clin North Am 31:39–47CrossRef
Dornelas EA, Sears SF (2018) Living with heart despite recurrent challenges: psychological care for adults with advanced cardiac disease. Am Psychol 73:1007–1018CrossRef
Doyle F, McGee H, Delaney M, Motterlini N, Conroy R (2011) Depressive vulnerabilities predict depression status and trajectories of depression over 1 year in persons with acute coronary syndrome. Gen Hosp Psychiatry 33:224–231CrossRef
Doyle F, McGee H, Conroy R et al (2015) Systematic review and individual patient data meta-analysis of sex differences in depression and prognosis in persons with myocardial infarction: a MINDMAPS study. Psychosom Med 77:419–428CrossRef
Doyle F, Freedland KE, Carney RM et al (2021) Hybrid systematic review and network meta-analysis of randomized controlled trials of interventions for depressive symptoms in patients with coronary artery disease. Psychosom Med 83:423–431CrossRef
Dragano N, Dragano N, Siegrist J, Nyberg ST et al (2017) Effort-reward imbalance at work and incident coronary heart disease: a multi-cohort study of 90,164 individuals. Epidemiology 28:619–626CrossRef
Drenckhan I, Glöckner-Rist A, Rist F et al (2015) Dimensional structure of bodily panic attack symptoms and their specific connections to panic cognitions, anxiety sensitivity and claustrophobic fears. Psychol Med 45:1675–1685CrossRef
DuBois CM, Lopez OV, Beale EE et al (2015) Relationships between positive psychological constructs and health outcomes in patients with cardiovascular disease: a systematic review. Int J Cardiol 195:265–280CrossRef
Easton K, Coventry P, Lovell K, Carter LA, Deaton C (2016) Prevalence and measurement of anxiety in samples of patients with heart failure: meta-analysis. J Cardiovasc Nurs 31:367–379CrossRef
Eckert A (2009) Spezielle Arzneimittelinteraktionen. Ther Umschau 66:485–492CrossRef
Eddy P, Wertheim EH, Kingsley M, Wright BJ (2017) Associations between the effort-reward imbalance model of workplace stress and indices of cardiovascular health: a systematic review and meta-analysis. Neurosci Biobehav Rev 83:252–266CrossRef
Edmondson D (2014) An enduring somatic threat model of posttraumatic stress disorder due to acute life-threatening medical events. Soc Personal Psychol Compass 8:118–134
Edmondson D, Cohen BE (2013) Posttraumatic stress disorder and cardiovascular disease. Prog Cardiovasc Dis 55:548–556CrossRef
Edmondson D, von Känel R (2017) Posttraumatic stress disorder and cardiovascular disease. Lancet Psychiatry 4:320–329CrossRef
Edmondson D, Rieckmann N, Shaffer JA et al (2011) Posttraumatic stress due to an acute coronary syndrome increases risk of 42-month major adverse cardiac events and all-cause mortality. J Psychiatr Res 45(12):1621–1626CrossRef
Edmondson D, Richardson S, Falzon L et al (2012) Posttraumatic stress disorder prevalence and risk of recurrence in acute coronary syndrome patients: a meta-analytic review. PLoS ONE 7(6):e38915CrossRef
Edmondson D, Kronish IM, Shaffer JA, Falzon L, Burg MM (2013a) Posttraumatic stress disorder and risk for coronary heart disease: a meta-analytic review. Am Heart J 166:806–814CrossRef
Edmondson D, Newman JD, Whang W, Davidson KW (2013b) Emotional triggers in myocardial infarction: do they matter? Eur Heart J 34:300–306CrossRef
Edmondson D, Birk JL, Ho VT et al (2018) A challenge for psychocardiology: addressing the causes and consequences of patientsʼ perceptions of enduring somatic threat. Am Psychol 73:1160–1171CrossRef
Eitel I, von Knobelsdorff-Brenkenhoff F, Bernhardt P et al (2011) Clinical characteristics and cardiovascular magnetic resonance findings in stress (Takotsubo) cardiomyopathy. JAMA 306:277–286
Elsayed AM, Brinjikji W, Salka S (2012) Demographic and co-morbid predictors of stress (takotsubo) cardiomyopathy. Am J Cardiol 110:1368–1372CrossRef
Emdin CA, Odutayo A, Wong CX et al (2016a) Meta-analysis of anxiety as a risk factor for cardiovascular disease. Am J Cardiol 118:511–519CrossRef
Eslami B (2017) Correlates of posttraumatic stress disorder in adults with congenital heart disease. Congenit Heart Dis 12:357–363CrossRef
Esler M (2017) Mental stress and human cardiovascular disease. Neurosci Biobehav Rev 74:269–276CrossRef
Eswarappa M, Neylan TC, Whooley MA et al (2019) Inflammation as a predictor of disease course in posttraumatic stress disorder and depression: a prospective analysis from the Mind Your Heart Study. Brain Behav Immun 75:220–227CrossRef
Fait K, Vilchinsky N, Dekel R et al (2018) Cardiac-disease-induced PTSD and Fear of illness progression: capturing the unique nature of disease-related PTSD. Gen Hosp Psychiatry 53:131–138CrossRef
Farah T, Ling S, Raine A, Yang Y, Schug R (2018) Alexithymia and reactive aggression: the role of the amygdala. Psychiatry Res Neuroimaging 281:85–91CrossRef
Farquhar JM, Stonerock GL, Blumenthal JA (2018) Treatment of anxiety in patients with coronary heart disease: a systematic review. Psychosomatics 5:318–332
Fernandes N, Prada L, Rosa MM, et al. (2021) The impact of SSRIs on mortality and cardiovascular events in patients with coronary artery disease and depression: systematic review and meta-analysis. Clin Res Cardiol 110:183–19
Fiedorowicz JG (2014) Depression and cardiovascular disease: an update on how course of illness may influence risk. Curr Psychiatry Rep 16:492CrossRef
Fishta A, Backé EM (2015) Psychosocial stress at work and cardiovascular diseases: an overview of systematic reviews. Int Arch Occup Environ Health 88:997–1014
Fonkoue IT, Michopoulos V, Park J (2020) Sex differences in post-traumatic stress disorder risk: autonomic control and inflammation. Clin Auton Res 30:409–421CrossRef
Frank P, Jokela M, Batty GD et al (2021) Association between systemic inflammation and individual symptoms of depression: a pooled analysis of 15 population-based cohort studies. Am J Psychiatry 178:1107–1118CrossRef
Frasure-Smith N, Lesperance F, Habra M et al (2009) Elevated depression symptoms predict long-term cardiovascular mortality in patients with atrial fibrillation and heart failure. Circulation 120:134–140CrossRef
Frasure-Smith N, Lespérance F (2010) Depression and cardiac risk: present status and future directions. Heart 96:173–176CrossRef
Freedland KE, Skala JA, Carney RM et al (2009) Treatment of depression after coronary artery bypass surgery: a randomized controlled trial. Arch Gen Psychiatry 66:387–396CrossRef
Freedland KE, Carney RM, Rich MW et al (2015) Cognitive behavior therapy for depression and self-care in heart failure patients: a randomized clinical trial. JAMA Intern Med 175:1773–1782CrossRef
Frestad D, Prescott E (2017) Vital exhaustion and coronary heart disease risk: a systematic review and meta-analysis. Psychosom Med 79:260–272CrossRef
Friedman M, Rosenman RH (1959) Association of specific overt behavior pattern with blood and cardiovascular findings; blood cholesterol level, blood clotting time, incidence of arcus senilis, and clinical coronary artery disease. JAMA 169:1286–1296CrossRef
Friedmann E, Thomas SA, Liu F et al (2006) Relationship of depression, anxiety, and social isolation to chronic heart failure outpatient mortality. Am Heart J 152:940.e1–8CrossRef
Fudim M, Cerbin LP, Devaraj S et al (2018) Post-traumatic stress disorder and heart failure in men with the Veteran Affairs Health System. Am J Cardiol 122:275–278CrossRef
Gander ML, von Kanel R (2006) Myocardial infarction and posttraumatic stress disorder: frequency, outcome, and atherosclerotic mechanisms. Eur J Cardiovasc Prev Rehabil 13:165–172CrossRef
Garg PK, OʼNeal WT, Diez-Roux AV et al (2019) Negative affect and risk of atrial fibrillation: MESA. J Am Heart Assoc 8:e010603CrossRef
Gary RA, Cress ME, Higgins MK, Smith AL, Dunbar SB (2012) A combined aerobic and resistance exercise program improves physical functional performance in patients with heart failure: a pilot study. Cardiovasc Nurs 27:418–430CrossRef
GBD (2017) Mortality and Causes of Death Collaborators (2018) Global, regional and national age-sex specific mortality for 282 causes of death, 1980–2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet 392(10159):1736–1788
Geulayov G, Novikov I, Dankner D, Dankner R (2018) Symptoms of depression and anxiety and 11-year all-cause mortality in men and women undergoing coronary artery bypass graft (CABG) surgery. J Psychosom Res 105:106–114CrossRef
Ghiadoni L, Donald AE, Cropley M et al (2000) Mental stress induces transient endothelial dysfunction in humans. Circulation 102:2473–2478CrossRef
Ghosh RK, Ball S, Prasad V, Gupta A (2016) Depression in heart failure: intricate relationship, pathophysiology and most updated evidence of interventions from recent clinical studies. Int J Cardiol 224:170–177CrossRef
Gianaros PJ, Onyewuenyi IC, Sheu LK et al (2012) Brain systems for baroreflex suppression during stress in humans. Hum Brain Mapp 33:1700–1716CrossRef
Gimbrone MA Jr, García-Cardeña G (2016) Endothelial cell dysfunction and the pathobiology of atherosclerosis. Circ Res 118:620–636CrossRef
Gjeilo KH, Stenseth R, Wahba A et al (2017) Chronic postsurgical pain in patients 5 years after cardiac surgery: a prospective cohort study. Eur J Pain 21:425–433CrossRef
Glassman AH (2005) Does treating post-myocardial infarction depression reduce medical mortality? Arch Gen Psychiatry 62:711–712CrossRef
Glassman A (2008) Depression and cardiovascular disease. Pharmacopsychiatry 41:221–225CrossRef
Glassman AH, Rodriguez AI, Shapiro PA (1998) The use of antidepressant drugs in patients with heart disease. J Clin Psychiatry 59(suppl 10):16–21
Glassman AH, O’Connor CM, Califf RM et al (2002) For the Sertraline Antidepressant Heart Attack Randomized Trial (SADHART) Group. Sertraline treatment of major depression in patients with acute MI or unstable angina. JAMA 288:701–709CrossRef
Glassman AH, Bigger JT Jr, Gaffney M (2009) Psychiatric characteristics associated with long term mortality among 361 patients having an acute coronary syndrome and major depression: seven-year follow-up of SADHART participants. Arch Gen Psychiatry 66:1022–1029CrossRef
Goh AC, Wong S, Zaroff JG et al (2016) Comparing anxiety and depression in patients with takotsubo stress cardiomyopathy to those with acute coronary syndrome. J Cardiopulm Rehabil Prev 36:106–111CrossRef
Gonzalez-Jaramillo V, Portilla-Fernandez E, Glisic M et al (2019) Epigenetics and inflammatory markers: a systematic review of the current evidence. Int J Inflam 2019:6273680
Grace SL, Medina-Inojosa JR, Thomas RJ et al (2018) Antidepressant use by class: association with major adverse cardiac events in patients with coronary artery disease. Psychother Psychosom 87:85–94CrossRef
Gulliksson M, Burell G, Vessby B et al (2011) Randomized controlled trial of cognitive behavioral therapy vs standard treatment to prevent recurrent cardiovascular events in patients with coronary heart disease: Secondary Prevention in Uppsala Primary Health Care project (SUPRIM). Arch Intern Med 171:134–140CrossRef
Habibović M, Denollet J, Pedersen SS et al (2017) Posttraumatic stress and anxiety in patients with an implantable cardioverter defibrillator: trajectories and vulnerability factors. Pacing Clin Electrophysiol 40:817–882CrossRef
Hajós M, Fleishaker JC, Filipiak-Reisner JK et al (2004) The selective norepinephrine reuptake inhibitor antidepressant reboxetine: pharmacological and clinical profile. CNS Drug Rev 10:23–44CrossRef
Hao G, Youssef NA, Davis CL, Su S (2018) The role of DNA methylation in the association between childhood adversity and cardiometabolic disease. Int J Cardiol 255:168–174CrossRef
Haroon E, Raison CL, Miller AH (2012) Psychoneuroimmunology meets neuropsychopharmacology: translational implications of the impact of inflammation on behavior. Neuropsychopharmacology 37:137–162CrossRef
Haukkala A, Konttinen H, Laatikainen T et al (2010) Hostility, anger control, and anger expression as predictors of cardiovascular disease. Psychosom Med 72:556–562CrossRef
Headrick JP, Peart JN, Budiono BP et al (2017) The heartbreak of depression: ʻPsycho-cardiacʼ coupling in myocardial infarction. J Mol Cell Cardiol 106:14–28CrossRef
Herrmann-Lingen C (2018) Chronische Herzinsuffizienz und Depression. Internist 59:445–452CrossRef
Herrmann-Lingen C (2019) Psychokardiologie – aktuelle Leitlinien und klinische Realität. Psychother Psychosom Med Psychol 69:237–252CrossRef
Herrmann-Lingen C, alʼAbsi M (2018) Exploring the association of hypertension with risk for depression: evidence for tamed neurobehavioral arousal versus central emotional dysregulation. Psychosom Med 80:504–507
Herrmann-Lingen C, Beutel ME, Bosbach A et al (2016) A stepwise psychotherapy intervention for reducing risk in coronary artery disease (SPIRR-CAD): results of an observer-blinded, multicenter, randomized trial in depressed patients with coronary artery disease. Psychosom Med 78:704–715CrossRef
Hoirisch-Clapauch S (2022) Mechanisms affecting brain remodeling in depression: do all roads lead to impaired fibrinolysis? Mol Psychiatry 27:525–533CrossRef
Honig A, Kuyper AM, Schene AH et al (2007) Treatment of postmyocardial infarction depressive disorder: a randomized, placebocontrolled trial with mirtazapine. Psychosom Med 69:606–613CrossRef
Howard JT, Sosnov JA, Janak JC et al (2018) Associations of initial injury severity and posttraumatic stress disorder diagnoses with long-term hypertension risk after combat injury. Hypertension 71:824–832CrossRef
Huang M, Shah A, Su S et al (2018) Association of depressive symptoms and heart rate variability in Vietnam War-Era Twins: a longitudinal twin difference study. JAMA Psychiat 75:705–712CrossRef
Hughes K, Bellis MA, Hardcastle KA, et al. (2017) The effect of multiple adverse childhood experiences on health: a systematic review and meta-analysis. Lancet Pub Health 2:e356–e366
Hung MY, Mao CT, Hung MJ et al (2019) Coronary artery spasm as related to anxiety and depression: a nationwide population-based study. Psychosom Med 81:237–245CrossRef
Ichikura K, Kobayashi S, Matsuoka S et al (2017) Avoidance behavior associated with depressive symptoms in patients with implantable cardioverter defibrillators. Int J Clin Health Psychol 17:1–8CrossRef
Israelsson J, Thylén I, Strömberg A (2018) Factors associated with health-related quality of life among cardiac arrest survivors treated with an implantable cardioverter-defibrillator. Resuscitation 132:78–84CrossRef
Jabbar A, Pingitore A, Pearce SH et al (2017) Thyroid hormones and cardiovascular disease. Nat Rev Cardiol 14:39–55CrossRef
Jackson CA, Pathirana T, Gardiner PA (2016) Depression, anxiety and risk of hypertension in mid-aged women: a prospective longitudinal study. Hypertens 34:1959–1966CrossRef
Jackson JL, Leslie CE, Hondorp SN (2018) Depressive and anxiety symptoms in adult congenital heart disease: prevalence, health impact and treatment. Prog Cardiovasc Dis 61:294–299CrossRef
Jacobi F, Höfler M, Strehle J et al (2014) Psychische Störungen in der Allgemeinbevölkerung. Studie zur Gesundheit Erwachsener in Deutschland und ihr Zusatzmodul Psychische Gesundheit (DEGS1-MH). Nervenarzt 85:77–87CrossRef
Jacquet-Smailovic M, Tarquinio C, Alla F et al (2021) Posttraumatic stress disorder following myocardial infarction: a systematic review. J Trauma Stress 34:190–199CrossRef
Jacquet-Smailovic M, Brennsthul MJ, Denis I et al (2022) Relationship between post-traumatic stress disorder and subsequent myocardial infarction: a systematic review and meta-analysis. J Affect Disord 297:525–535CrossRef
Jakubowski KP, Cundiff JM, Matthews KA (2017) Cumulative childhood adversity and adult cardiometabolic disease: a meta-analysis. Health Psychol 37:701–715CrossRef
James SP, Mendelson WB (2004) The use of trazodone as a hypnotic: a critical review. J Clin Psychiatry 65(6):752–755CrossRef
Jeong SW, Kim SH, Kang SH, et al. (2019) Mortality reduction with physical activity in patients with and without cardiovascular disease. Eur Heart J 40:3547–3555
Jeyanantham K, Kotecha D, Thanki D et al (2017) Effects of cognitive behavioural therapy for depression in heart failure patients: a systematic review and meta-analysis. Heart Fail Rev 22:731–741CrossRef
Jiang W, Davidson J (2005) Antidepressant therapy in patients with ischemic heart disease. Am Heart J 150:871–881CrossRef
Jiang W, Kuchibhatla M, Cuffe MS et al (2004) Prognostic value of anxiety and depression in patients with chronic heart failure. Circulation 110:3452–3456CrossRef
Jokinen J, Nordström P (2009) HPA axis hyperactivity and cardiovascular mortality in mood disorder inpatients. J Affect Disord 116:88–92CrossRef
Jolly K, Langman MJ (2009) Psychotropic medication: curing illness or creating problems? Heart 95:1893–1894CrossRef
Jordan HT, Miller-Archie SA, Cone JE et al (2011) Heart disease among adults exposed to the September 11, 2001 World Trade Center disaster: results from the World Trade Center Health Registry. Prev Med 53:370–376CrossRef
Jordan HT, Stellman SD, Morabia A et al (2013) Cardiovascular disease hospitalizations in relation to exposure to the September 11, 2001 World Trade Center disaster and posttraumatic stress disorder. J Am Heart Assoc 2:e000431CrossRef
Joseph P, Leong D, McKee M et al (2017) Reducing the global burden of cardiovascular disease, part 1 – the epidemiology and risk factors. Circ Res 121:677–694CrossRef
Kandasamy S, Anand SS (2018) Cardiovascular disease among women from vulnerable populations: a review. Can J Cardiol 34:450–457CrossRef
Kapfhammer HP (2017a) Akute und posttraumatische Belastungsstörung. In: Möller HJ, Laux G, Kapfhammer HP (Hrsg) Psychiatrie, Psychosomatik und Psychotherapie, Bd 3, 5. Aufl. Springer, Berlin, S 1965–2040CrossRef
Kapfhammer HP (2017b) Psychosomatische Medizin – Einleitung und Übersicht. In: Möller HJ, Laux G, Kapfhammer HP (Hrsg) Psychiatrie, Psychosomatik und Psychotherapie, Bd 4, 5. Aufl. Springer, Berlin, S 2645–2667CrossRef
Kapfhammer HP (2017c) Somatoforme Störungen – somatoforme Belastungsstörung und verwandte Störungen. In: Möller HJ, Laux G, Kapfhammer HP (Hrsg) Psychiatrie, Psychosomatik und Psychotherapie, Bd 3, 5. Aufl. Springer, Berlin, S 2015–2253
Kapfhammer HP (2017d) Psychische Störungen bei somatischen Krankheiten. In: Möller HJ, Laux G, Kapfhammer HP (Hrsg) Psychiatrie, Psychosomatik und Psychotherapie, Bd 4, 5. Aufl. Springer, Berlin, S 2693–2805CrossRef
Kapfhammer HP (2018) Acute and long-term mental and physical sequelae in the aftermath of traumatic exposure – some remarks on “the body keeps the score”. Psychiatr Danubina 30:254–272CrossRef
Kaptoge S, Seshasai SR, Gao P et al (2014) Inflammatory cytokines and risk of coronary heart disease: new prospective study and updated meta-analysis. Eur Heart J 35:578–589CrossRef
Karhova M, Treichel U, Malago M et al (2000) Interaction of Hypericum perforatum (St. John’s wort) with ciclosporin. A metabolism in a patient after liver transplantation. J Hepatol 33:853–855CrossRef
Kasmi L, Calderon J, Montreuil M et al (2018) Neurocognitive and psychological outcomes in adults with dextro-transposition of the great arteries corrected by the arterial switch operation. Ann Thorac Surg 105:830–836CrossRef
Katon WJ, Lin EHB, Von Korff M et al (2010) Collaborative care for patients with depression and chronic illness. N Engl J Med 363:2611–2620CrossRef
Katon W, Russo J, Lin EH, Schmittdiel J et al (2012) Cost-effectiveness of a multicondition collaborative care intervention: a randomized controlled trial. Arch Gen Psychiatry 69:506–514CrossRef
Kažukauskienė N, Burkauskas J, Macijauskienė J et al (2019) Stressful life events are associated with health-related quality of life during cardiac rehabilitation and at 2-yr follow-up in patients with heart failure. J Cardiopulm Rehabil Prev 39:E5–E8CrossRef
Khan SA, Shahzad U, Zarak MS et al (2021) Association of depression with subclinical coronary atherosclerosis: a systematic review. J Cardiovasc Transl Res 14:685–705CrossRef
Kendler KS, Gardner CO, Fiske A, Gatz M (2009) Major depression and coronary artery disease in the Swedish Twin Registry. Arch Gen Psychiatry 66:857–863CrossRef
Kent LK, Shapiro PA (2009) Depression and related psychological factors in heart disease. Harv Rev Psychiatry 17:377–388CrossRef
Khalid N, Ahmad SA, Shlofmitz E et al (2019) Takotsubo cardiomyopathy: prognostication is affected by the underlying trigger. J Cardiovasc Med 20:409–410CrossRef
Khoury NM, Marvar PJ, Gillespie CF et al (2012) The renin-angiotensin pathway in posttraumatic stress disorder: angiotensin-converting enzyme inhibitors and angiotensin receptor blockers are associated with fewer traumatic stress symptoms. J Clin Psychiatry 73:849–855CrossRef
Kibler JL (2009) Posttraumatic stress disorder and cardiovascular disease risk. J Trauma Dissociation 10:135–150CrossRef
Kido K, Guglin M (2017) Drug-induced takotsubo cardiomyopathy. J Cardiovasc Pharmacol Ther 22:552–563CrossRef
Kim JM, Bae KY, Stewart R et al (2015) Escitalopram treatment for depressive disorder following acute coronary syndrome: a 24-week double-blind, placebo-controlled trial. J Clin Psychiatry 76:62–68CrossRef
Kim JM, Stewart R, Lee YS et al (2018) Effect of escitalopram vs placebo treatment for depression on long-term cardiac outcomes in patients with acute coronary syndrome: a randomized clinical trial. JAMA 320:350–358CrossRef
Kivimäki M, Kawachi I (2015) Work stress as a risk factor for cardiovascular disease. Curr Cardiol Rep 17:630–639CrossRef
Kivimäki M, Steptoe A (2018) Effects of stress on the development and progression of cardiovascular disease. Nat Rev Cardiol 15:215–229CrossRef
Kivimäki M, Jokela M, Nyberg ST et al (2015) Long working hours and risk of coronary heart disease and stroke: a systematic review and meta-analysis of published and unpublished data for 603 838 individuals. Lancet 386:1739–1746CrossRef
Klempfner R, Koifman E, Goldenberg I et al (2014) The Israel nationwide heart failure survey: sex differences in early and late mortality for hospitalized heart failure patients. J Card Fail 20:193–198CrossRef
Köbe J, Hucklenbroich K, Geisendörfer N et al (2017) Posttraumatic stress and quality of life with the totally subcutaneous compared to conventional cardioverter-defibrillator systems. Clin Res Cardiol 106:317–321CrossRef
Koenen KC, Sumner JA, Gilsanz P et al (2017) Post-traumatic stress disorder and cardiometabolic disease: improving causal inference to inform practice. Psychol Med 47:209–225CrossRef
Konstam V, Salem D, Pouleur H et al (1996) Baseline quality of life as a predictor of mortality and hospitalization in 5,025 patients with congestive heart failure. SOLVD Investigations. Studies of Left Ventricular Dysfunction Investigators. Am J Cardiol 78:890–895CrossRef
Korkeila J, Vahtera J, Korkeila K et al (2010) Childhood adversities as predictors of incident coronary heart disease and cerebrovascular disease. Heart 96:298–303CrossRef
Kovacs AH, Saidi AS, Kuhl EA et al (2009) Depression and anxiety in adult congenital heart disease: predictors and prevalence. Int J Cardiol 137:158–164CrossRef
Krantz DS, Whittaker KS, Francis JL et al (2009) Psychotropic medication use and risk of adverse cardiovascular events in women with suspected coronary artery disease: outcome from the Women’ s Ischemia Syndrome Evaluation (WISE) study. Heart 95:1901–1906CrossRef
Kubzansky LD, Davidson KW, Rozanski A (2005) The clinical impact of negative psychological states: expanding the spectrum of risk for coronary artery disease. Psychosom Med 67(suppl 1):S10–S14CrossRef
Kubzansky LD, Huffman JC, Boehm JK et al (2018) Positive psychological well-being and cardiovascular disease: JACC Health Promotion Series. J Am Coll Cardiol 72:1382–1396CrossRef
Kupper N, Denollet J (2016) Explaining heterogeneity in the predictive value of Type D personality for cardiac events and mortality. Int J Cardiol 224:119–124CrossRef
Kuyper AMG, Honig A (2008) Treatment of post-myocardial infarction depressive disorder. Expert Rev Neurother 8:1115–1123CrossRef
Kupper N, Boomsma DI, de Geus EJ, Denollet J, Willemsen G (2011) Nine-year stability of typeD personality: contributions of genes and environment. Psychosom Med 73:75–82CrossRef
Ladwig KH, Lurz J, Lukaschek K (2022) Herzerkrankungen im Langzeitverlauf: Wie kann die psychosoziale Versorgung verbessert werden? Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 65:481–487CrossRef
Lambertus F, Herrmann-Lingen C, Fritzsche K et al (2018) Prevalence of mental disorders among depressed coronary patients with and without Type D personality. Results of the multi-center SPIRR-CAD trial. Gen Hosp Psychiatry 50:69–75CrossRef
Lane RD, Jennings JR (1995) Hemispheric asymmetry, autonomic asymmetry and the problem of sudden cardiac death. In: Davidson RJ, Hugdahl K (Hrsg) Brain asymmetry. MIT Press, Cambridge, S 271–304
Lange R (2012) Koronare Herzkrankheit. In: Siewert JR, Stein HJ (Hrsg) Chirurgie, 9. Aufl. Springer, Berlin, S 403–409
Langvik E, Hjemdal O (2015) Symptoms of depression and anxiety before and after myocardial infarction: the HUNT 2 and HUNT 3 study. Psychol Health Med 20:560–569CrossRef
Larsen KK (2013) Depression following myocardial infarction–an overseen complication with prognostic importance. Dan Med J 60:B4689
Larsen KK, Christensen B, Nielsen TJ, Vestergaard M (2014) Post-myocardial infarction anxiety or depressive symptoms and risk of new cardiovascular events or death: a population-based longitudinal study. Psychosom Med 76:739–746CrossRef
Lawes S, Demakakos P, Steptoe A et al (2019) Combined influence of depressive symptoms and systemic inflammation on all-cause and cardiovascular mortality: evidence for differential effects by gender in the English Longitudinal Study of Ageing. Psychol Med 49:1521–1531CrossRef
Le Mellédo JM, Mahil N, Baker GB (2004) Nitric oxide: a key player in the relation between cardiovascular disease and major depressive disorder? J Psychiatry Neurosci 29:414–416
Leigh-Hunt N, Bagguley D, Bash K et al (2017) An overview of systematic reviews on the public health consequences of social isolation and loneliness. Public Health 152:157–171CrossRef
Lenane Z, Peacock E, Joyce C et al (2019) Association of post-traumatic stress disorder symptoms following Hurricane Katrina with incident cardiovascular disease events among older adults with hypertension. Am J Geriatr Psychiatry 27:310–321CrossRef
Lespérance F, Frasure-Smith N, Talajic M, Bourassa MG (2002) Five-year risk of cardiac mortality in relation to initial severity and one-year changes in depression symptoms after myocardial infarction. Circulation 105:1049–1053
Lespérance F, Frasure-Smith N, Koszycki D et al (2007) Effects of citalopram and interpersonal psychotherapy on depression in patients with coronary artery disease: the Canadian Cardiac Randomized Evaluation of Antidepressant and Psychotherapy Efficacy (CREATE) trial. JAMA 297:367–379CrossRef
Lett HS, Sherwood A, Watkins L, Blumenthal JA (2006) Depression and prognosis in cardiac patients. In: Steptoe A (Hrsg) Depression and physical illness. Cambridge University Press, Cambridge, S 87–108CrossRef
Levine AB, Levine LM, Levine TB (2014) Posttraumatic stress disorder and cardiometabolic disease. Cardiology 127:1–19CrossRef
Li Q, Du Q (2020) Associations between nine candidate genetic polymorphisms with coronary heart disease: A meta-analysis. Herz 45(suppl 1):15–28CrossRef
Li YN, Buys N, Ferguson S et al (2021) Effectiveness of cognitive behavioral therapy-based interventions on health outcomes in patients with coronary heart disease: a meta-analysis. World J Psychiatry 11:1147–1166CrossRef
Lichtman JH, Froelicher ES, Blumenthal JA et al (2014) Depression as a risk factor for poor prognosis among patients with acute coronary syndrome: systematic review and recommendations: a scientific statement from the American Heart Association. Circulation 129:1350–1369CrossRef
Liguori I, Russo G, Curcio F et al (2018) Depression and chronic heart failure in the elderly: an intriguing relationship. J Geriatr Cardiol 15:451–459
Lim LF, Solmi M, Cortese S (2021) Association between anxiety and hypertension in adults: a systematic review and meta-analysis. Neurosci Biobehav Rev 131:96–119CrossRef
Lin EH, Von Korff M, Ciechanowski P et al (2012) Treatment adjustment and medication adherence for complex patients with diabetes, heart disease, and depression: a randomized controlled trial. Ann Fam Med 10:6–14CrossRef
Lin P, Li L, Wang Y, Zhao Z, Liu G et al (2018) Type D personality, but not type a behavior pattern, is associated with coronary plaque vulnerability. Psychol Health Med 23:216–223CrossRef
Lin TK, Hsu BC, Li YD et al (2019) Prognostic value of anxiety between heart failure with reduced ejection fraction and heart failure with preserved ejection fraction. J Am Heart Assoc 8(12):e010739CrossRef
Lip GY, Tse HF, Lane DA (2012) Atrial fibrillation. Lancet 379(9816):648–661CrossRef
Liu MY, Li N, Li WA, Khan H (2017) Association between psychosocial stress and hypertension: a systematic review and meta-analysis. Neurol Res 39:573–580CrossRef
Liu H, Tian Y, Liu Y, Nigatu YT, Wang J (2019a) Relationship between major depressive disorder, generalized anxiety disorder and coronary artery disease in the US general population. J Psychosom Res 119:8–13CrossRef
Lohse T, Rohrmann S, Richard A et al (2017) Type A personality and mortality: competitiveness but not speed is associated with increased risk. Atherosclerosis 262:19–24CrossRef
Long J, Duan G, Tian W et al (2015) Hypertension and risk of depression in the elderly: a meta-analysis of prospective cohort studies. J Hum Hypertens 29:478–482CrossRef
Lunde ED, Nielsen PB, Riahi S et al (2018) Associations between socioeconomic status, atrial fibrillation, and outcomes: a systematic review. Expert Rev Cardiovasc Ther 16:857–873CrossRef
Lyon AR, Bossone E, Schneider B et al (2016) Current state of knowledge on Takotsubo syndrome: a position statement from the Taskforce on Takotsubo Syndrome of the Heart Failure Association of the European Society of Cardiology. Eur J Heart Fail 18:8–27CrossRef
Lyon AR, Citro R, Schneider B et al (2021) Pathophysiology of Takotsubo Syndrome: JACC state-of-the-art review. J Am Coll Cardiol 77:902–921CrossRef
Maes M, Yirmyia R, Noraberg J et al (2009) The inflammatory & neurodegenerative (I&ND) hypothesis of depression: leads for future research and new drug developments in depression. Metab Brain Dis 24:27–53CrossRef
Magán I, Casado L, Jurado-Barba R et al (2021) Efficacy of psychological interventions on psychological outcomes in coronary artery disease: systematic review and meta-analysis. Psychol Med 51:1846–1860CrossRef
Magyar-Russell G, Thombs BD, Cai JX, et al. (2011) The prevalence of anxiety and depression in adults with implantable cardioverter defibrillators: a systematic review. J Psychosom Res 71:223–3
Malt UF, Lloyd GG (2007) Psychopharmacological treatment in liaison psychiatry. In: Llyod GG, Guthrie E (Hrsg) Handbook of liaison psychiatry. Cambridge University Press, Cambridge, S 763–794CrossRef
Martens EJ, de Jonge P, Na B et al (2010a) Scared to death? Generalized anxiety disorder and cardiovascular events in patients with stable coronary heart disease: the Heart and Soul Study. Arch Gen Psychiatry 67:750–758CrossRef
Martens EJ, Hoen PW, Mittelhaeuser M et al (2010b) Symptom dimensions of post-myocardial infarction depression, disease severity and cardiac prognosis. Psychol Med 40:807–814CrossRef
Masafi S, Saadat SH, Tehranchi K et al (2018) Effect of stress, depression and type D personality on immune system in the incidence of coronary artery disease. Open Access Maced J Med Sci 6:1533–1544CrossRef
Mastenbroek MH, Versteeg H, Jordaens L et al (2014) Ventricular tachyarrhythmias and mortality in patients with an implantable cardioverter defibrillator: impact of depression in the MIDAS cohort. Psychosom Med 76:58–65CrossRef
Mavrides N, Nemeroff CB (2015) Treatment of affective disorders in cardiac disease. Dialogues Clin Neurosci 17:127–140CrossRef
Mazereeuw G, Herrmann N, Oh PI et al (2016) Omega-3 fatty acids, depressive symptoms, and cognitive performance in patients with coronary artery disease: analyses from a randomized, double-blind, placebo-controlled trial. J Clin Psychopharmacol 36:436–444CrossRef
Mazza M, Lotrionte M, Biondi-Zoccai G et al (2010) Selective serotonin reuptake inhibitors provide significant lower re-hospitalization rates in patients recovering from acute coronary syndromes: evidence from a meta-analysis. J Psychopharmacol 24:1785–1792CrossRef
Mazzeo AT, Micalizzi A, Mascia L et al (2014) Brain-heart crosstalk: the many faces of stress-related cardiomyopathy syndromes in anaesthesia and intensive care. Br J Anaesth 112:803–815CrossRef
McFarlane A, Kamath MV, Fallen EL et al (2001) Effect of sertraline on the recovery rate of cardiac autonomic function in depressed patientsafter acute myocardial infarction. Am Heart J 142:617–623CrossRef
McKenzie LH, Simpson J, Stewart M (2010) A systematic review of pre-operative predictors of post-operative depression and anxiety in individuals who have undergone coronary artery bypass graft surgery. Psychol Health Med 15:74–93CrossRef
Medina de Chazal H, Del Buono MG, Keyser-Marcus L et al (2018) Stress cardiomyopathy diagnosis and treatment. JACC state-of-the-art review. J Am Coll Cardiol 72:1955–1971CrossRef
Mehta PK, Wei J, Wenger NK (2015) Ischemic heart disease in women: a focus on risk factors. Trends Cardiovasc Med 25:140–151CrossRef
Mehta PK, Johnson BD, Kenkre TS et al (2017) Sudden cardiac death in women with suspected ischemic heart disease, preserved ejection fraction, and no obstructive coronary artery disease: a report from the Women's Ischemia Syndrome Evaluation Study. J Am Heart Assoc 6. pii: e005501. https://​doi.​org/​10.​1161/​JAHA.​117.​005501
Mehta PK, Thobani A, Vaccarino V (2019) Coronary artery spasm, coronary reactivity, and their psychological context. Psychosom Med 81:233–236CrossRef
Meijer A, Conradi HJ, Bos EH et al (2011) Prognostic association of depression following myocardial infarction with mortality and cardiovascular events: a meta-analysis of 25 years of research. Gen Hosp Psychiatry 33:203–216CrossRef
Meijer A, Conradi HJ, Bos EH et al (2013a) Adjusted prognostic association of depression following myocardial infarction with mortality and cardiovascular events: individual patient data metaanalysis. Br J Psychiatry 203:90–102CrossRef
Meng L, Chen D, Yang Y, Zheng Y, Hui R (2012) Depression increases the risk of hypertension incidence: a meta-analysis of prospective cohort studies. J Hypertens 30:842–851CrossRef
Meyer T, Buss U, Hermann-Lingen C (2010) Role of cardiac disease severity in the predictive value of anxiety for all-cause mortality. Psychosom Med 72:9–15CrossRef
Meyer T, Belnap BH, Herrmann-Lingen C et al (2014) Benefits of collaborative care for post-CABG depression are not related to adjustments in antidepressant pharmacotherapy. J Psychosom Res 76:28–33CrossRef
Milaneschi Y, Kappelmann N, Ye Z et al (2021) Association of inflammation with depression and anxiety: evidence for symptom-specificity and potential causality from UK Biobank and NESDA cohorts. Mol Psychiatry 26:7393–7402CrossRef
Miller AH, Raison CL (2016) The role of inflammation in depression: from evolutionary imperative to modern treatment target. Nat Rev Immunol 16:22–34CrossRef
Miller MW, Lin AP, Wolf EJ, Miller DR (2018) Oxidative stress, inflammation, and neuroprogression in chronic PTSD. Harvard Rev Psychiatry 26:57–69CrossRef
Miller JL, Thylén I, Elayi SC et al (2019) Multi-morbidity burden, psychological distress, and quality of life in implantable cardioverterdefibrillator recipients: results from a nationwide study. J Psychosom Res 120:39–45CrossRef
Minhas AS, Hughey AB, Kolias TJ (2015) Nationwide trends in reported incidence of Takotsubo Cardiomyopathy from 2006 to 2012. Am J Cardiol 116:1128–1131CrossRef
Moazzami K, Dolmatova EV, Feurdean M (2018) Suicidal ideation among adults with cardiovascular disease: The National Health and Nutrition Examination Survey. Gen Hosp Psychiatry 51:5–9CrossRef
Mørch RH, Dieset I, Færden A et al (2019) Inflammatory markers are altered in severe mental disorders independent of comorbid cardiometabolic disease risk factors. Psychol Med 49:1749–1757CrossRef
Morris G, Walker AJ, Berk M et al (2018) Cell death pathways: a novel therapeutic approach for neuroscientists. Mol Neurobiol 55:5767–5786CrossRef
Muka T, Koromani F, Portilla E et al (2016) The role of epigenetic modifications in cardiovascular disease: a systematic review. Int J Cardiol 212:174–183CrossRef
Münzel T, Camici GG, Maack C et al (2017) Impact of oxidative stress on the heart and vasculature: part 2 of a 3-part series. J Am Coll Cardiol 70:212–229CrossRef
Musey PI Jr, Schultebraucks K, Chang BP (2020) Stressing out about the heart: a narrative review of the role of psychological stress in acute cardiovascular events. Acad Emerg Med 27:71–79CrossRef
Musunuru K, Kathiresan S (2019) Genetics of common, complex coronary artery disease. Cell 177:132–145CrossRef
Myrtek M (2001) Meta-analyses of prospective studies on coronary heart disease, type A personality, and hostility. Int J Cardiol 79:245–251CrossRef
Naber D, Bullinger M (2017) Psychiatric sequelae of cardiac arrest. Dialogues Clin Neurosci 20:73–77CrossRef
Narayan SM, Stein MB (2009) Do depression or antidepressants increase cardiovascular mortality? The absence of proof might be more important than the proof of absence. J Am Coll Cardiol 53:950–958CrossRef
Nasiłowska-Barud A, Zapolski T, Barud M, Wysokiński A (2017) Overt and covert anxiety as a toxic factor in ischemic heart disease in women: the link between psychological factors and heart disease. Med Sci Monit 23:751–758CrossRef
Nayeri A, Rafla-Yuan E, Farber-Eger E et al (2017) Pre-existing psychiatric illness is associated with increased risk of recurrent takotsubo cardiomyopathy. Psychosomatics 58:527–532CrossRef
Nayeri A, Rafla-Yuan E, Krishnan S et al (2018) Psychiatric illness in takotsubo (stress) cardiomyopathy: a review. Psychosomatics 59:220–226CrossRef
Newman JD, Davidson KW, Shaffer JA et al (2011) Observed hostility and the risk of incident ischemic heart disease: a prospective population study from the 1995 Canadian Nova Scotia Health Survey. J Am Coll Cardiol 58:1222–1228CrossRef
Nicholson A, Kuper H, Hemingway H (2006) Depression as an aetiologic and prognostic factor in coronary heart disease: a meta-analysis of 6362 events among 146 538 participants in 54 observational studies. Eur Heart J 7627:2763–2774CrossRef
Norlund F, Lissåker C, Wallert J et al (2018) Factors associated with emotional distress in patients with myocardial infarction: results from the SWEDEHEART registry. Eur J Prev Cardiol 25:910–920CrossRef
Novitzky D, Cooper DK (2014) Thyroid hormone and the stunned myocardium. J Endocrinol 223:R1–R8CrossRef
Nusslock R, Miller GE (2016) Early-life adversity and physical and emotional health across the lifespan: a neuro-immune network hypothesis. Biol Psychiatry 80:23–32CrossRef
Nylocks KM, Michopoulos V, Rothbaum AO et al (2015) An angiotensin-converting enzyme (ACE) polymorphism may mitigate the effects of angiotensin-pathway medications on posttraumatic stress symptoms. Am J Med Genet B Neuropsychiatr Genet 168B:307–315CrossRef
O’Connor CM, Jiang W, Kuchibhatla M et al (2010) Safety and efficacy of sertraline for depression in patients with heart failure: results of the SADHART-CHF (Sertraline Against Depression and Heart Disease in Chronic Heart Failure) trial. J Am Coll Cardiol 56:692–699CrossRef
O’Donnell CJ, Schwartz Longacre L, Cohen BE et al (2021) Posttraumatic stress disorder and cardiovascular disease: state of the science, knowledge gaps, and research opportunities. JAMA Cardiol 6:1207–1216CrossRef
O’Donovan A, Neylan TC (2017) Associations of trauma and posttraumatic stress disorder with inflammation and endothelial function: on timing, specificity, and mechanisms. Biol Psychiatry 82:861–863CrossRef
O’Neil A, Russell JD, Murphy B (2021) How does mental health impact women’s heart health? Heart Lung Circ 30:59–68CrossRef
Ostuzzi G, Turrini G, Gastaldon C et al (2019) Efficacy and acceptability of antidepressants in patients with ischemic heart disease: systematic review and meta-analysis. Int Clin Psychopharmacol 34:65–75CrossRef
Otto MW, Fitzgerald HE, Meyer-Pot MJ (2019) The potential role of anxiety sensitivity in the risk for and recovery from heart attacks: comment on Edmondson et al. (2018). Am Psychol 74:622–623CrossRef
Pan Y, Cai W, Cheng Q et al (2015) Association between anxiety and hypertension: a systematic review and meta-analysis of epidemiological studies. Neuropsychiatr Dis Treat 11:1121–1130
Papadis A, Svab S, Brugger N et al (2022) “Broken heart” and “broken Bbrain”: which connection? Cardiol Res 13:65–70CrossRef
Park J, Marvar PJ, Liao P et al (2017) Baroreflex dysfunction and augmented sympathetic nerve responses during mental stress in veterans with post-traumatic stress disorder. J Physiol 595:4893–4908CrossRef
Patel D, Mc Conkey ND, Sohaney R et al (2013) A systematic review of depression and anxiety in patients with atrial fibrillation: the mind-heart link. Cardiovasc Psychiatry Neurol 2013:159850
Patel JS, Berntson J, Polanka BM, Stewart JC (2018) Cardiovascular risk factors as differential predictors of incident atypical and typical major depressive disorder in US adults. Psychosom Med 80:508–514CrossRef
Patron E, Messerotti Benvenuti S, Palomba D (2014) Preoperative and perioperative predictors of reactive and persistent depression after cardiac surgery: a three-month follow-up study. Psychosomatics 55:261–271CrossRef
Peacock J, Whang W (2013) Psychological distress and arrhythmia: risk prediction and potential modifiers. Prog Cardiovasc Dis 55:582–589CrossRef
Pedersen SS, von Känel R, Tully PJ, Denollet J (2017) Psychosocial perspectives in cardiovascular disease. Eur J Prevent Cardiol 24:108–115CrossRef
Pelle AJ, Pedersen SS, Schiffer AA et al (2010) Psychological distress and mortality in systolic heart failure. Circ Heart Fail 3:261–267CrossRef
Penninx BWJH (2017) Depression and cardiovascular disease: epidemiological evidence on their linking mechanisms. Neurosci Biobehav Rev 74:277–286CrossRef
Penninx BW, Beekman AT, Honig A et al (2001) Depression and cardiac mortality: results from a community-based longitudinal study. Arch Gen Psychiatry 58:221–227CrossRef
Piercy KL, Troiano RP, Ballard RM, et al. (2018) The physical activity guidelines for Americans. JAMA 320:2020–2028
Pimple P, Hammadah M, Wilmot K et al (2019a) The relation of psychosocial distress with myocardial perfusion and stress-induced myocardial ischemia. Psychosom Med 81:363–371CrossRef
Piña IL, Di Palo KE, Ventura HO (2018) Psychopharmacology and cardiovascular disease. J Am Coll Cardiol 71:2346–2359CrossRef
Pitharouli MC, Hagenaars SP, Glanville KP et al (2021) Elevated C-reactive protein in patients with depression, independent of genetic, health, and psychosocial factors: results from the UK biobank. Am J Psychiatry 178:522–529CrossRef
Pizzi C, Rutjes AW, Costa GM et al (2011) Meta-analysis of selective serotonin reuptake inhibitors in patients with depression and coronary heart disease. Am J Cardiol 107:972–979CrossRef
Pizzi C, Santarella L, Bugiardini R (2014) Epidemiology and the physiopathological link between depression and cardiovascular disease. IJC Metabol Endocrine 5:52–55CrossRef
Polikandrioti M, Panoutsopoulos G, Tsami A et al (2019) Assessment of quality of life and anxiety in heart failure outpatients. Arch Med Sci Atheroscler Dis 4:e38–e46CrossRef
Poole L, Leigh E, Kidd T et al (2014) The combined association of depression and socioeconomic status with length of post-operative hospital stay following coronary artery bypass graft surgery: data from a prospective cohort study. J Psychosom Res 76:34–40CrossRef
Pries AR, Badimon L, Bugiardini R et al (2015) Coronary vascular regulation, remodelling, and collateralization: mechanisms and clinical implications on behalf of the working group on coronary pathophysiology and microcirculation. Eur Heart J 36:3134–3146CrossRef
Pristipino C, Roncella A, Pasceri V, Speciale G (2019) Short-TErm Psychotherapy IN Acute Myocardial Infarction (STEP-IN-AMI) Trial: final results. Am J Med 132:639–646CrossRef
Puozzo C, Panconi E, Deprez D (2002) Pharmacology and pharmacokinetics of milnacipran. Int Clin Psychopharmacol 17(suppl 1):25–35CrossRef
Quadt L, Critchley HD, Garfinkel SN (2018) The neurobiology of interoception in health and disease. Ann N Y Acad Sci 1428:112–128CrossRef
Rajeswaran T, Plymen CM, Doherty AM (2018) The effect of antidepressant medications in the management of heart failure on outcomes: mortality, cardiovascular function and depression – a systematic review. Int J Psychiatry Clin Pract 22:164–169CrossRef
Rattanawong P, Upala S, Riangwiwat T et al (2018) Atrial fibrillation is associated with sudden cardiac death: a systematic review and meta-analysis. J Interv Card Electrophysiol 51:91–104CrossRef
Rauch B, Davos CH, Doherty P et al (2016) The prognostic effect of cardiac rehabilitation in the era of acute revascularisation and statin therapy: a systematic review and meta-analysis of randomized and non-randomized studies – the Cardiac Rehabilitation Outcome Study (CROS). Eur J Prev Cardiol 23:1914–1939CrossRef
Reavell J, Hopkinson M, Clarkesmith D, Lane DA (2018) Effectiveness of cognitive behavioral therapy for depression and anxiety in patients with cardiovascular disease: a systematic review and meta-analysis. Psychosom Med 80:742–753CrossRef
Reich J, Schatzberg A (2010) Personality traits and medical outcome of cardiac illness. Psychiatr Res 44:1017–1020CrossRef
Ren Y, Jia J, Sa J et al (2017) Association between N-terminal proB-type natriuretic peptide and depressive symptoms in patients with acute myocardial infarction. Chin Med J 130:542–548CrossRef
Rewiuk K, Wizner B, Klich-Rączka A et al (2018) Atrial fibrillation independently linked with depression in community-dwelling older population. Results from the nationwide PolSenior project. Exp Gerontol 112:88–91CrossRef
Richards SH, Anderson L, Jenkinson CE et al (2018) Psychological interventions for coronary heart disease: Cochrane systematic review and meta-analysis. Eur J Prev Cardiol 25:247–259CrossRef
Richardson S, Shaffer JA, Falzon L et al (2012) Meta-analysis of perceived stress and its association with incident coronary heart disease. Am J Cardiol 110:1711–1716CrossRef
Rieckmann N, Kronish IM, Shapiro PA et al (2013) Serotonin reuptake inhibitor use, depression, and long-term outcomes after an acute coronary syndrome: a prospective cohort study. JAMA Intern Med 173:1150–1151CrossRef
Rigas A, Farmakis D, Papingiotis G et al (2018) Hypothalamic dysfunction in heart failure: pathogenetic mechanisms and therapeutic implications. Heart Fail Rev 23:55–61CrossRef
Riggs DW, Yeager RA, Bhatnagar A (2018) Defining the human envirome: an omics approach for assessing the environmental risk of cardiovascular disease. Circ Res 122:1259–1275CrossRef
Rigotti NA, Thorndike AN, Regan S et al (2006) Bupropion for smokers hospitalized with acute cardiovascular disease. Am J Med 119:1080–1087CrossRef
Röder C, Schaefer M, Leucht S (2004) Meta-Analyse zu Wirksamkeit und Verträglichkeit der Behandlung der leichten und mittelschweren Depression mit Johanniskraut. Fortschr Neurol Psychiatr 72:330–343CrossRef
Rodondi N, den Elzen WP, Bauer DC et al (2010) Subclinical hypothyroidism and the risk of coronary heart disease and mortality. JAMA 304:1365–1374CrossRef
Roest AM, Martens EJ, de Jonge P, Denollet J (2010a) Anxiety and risk of incident coronary heart disease: a meta-analysis. J Am Coll Cardiol 56:38–46CrossRef
Roest AM, Martens EJ, Denollet J, de Jonge P (2010b) Prognostic association of anxiety post myocardial infarction with mortality and new cardiac events: a meta-analysis. Psychosom Med 72:563–569CrossRef
Roest AM, Zuidersma M, de Jonge P (2012) Myocardial infarction and generalised anxiety disorder: 10-year follow-up. Br J Psychiatry 200:324–329CrossRef
Roest AM, Carney RM, Freedland KE et al (2013) Changes in cognitive versus somatic symptoms of depression and event-free survival following acute myocardial infarction in the Enhancing Recovery In Coronary Heart Disease (ENRICHD) study. J Affect Disord 149:335–341CrossRef
Roncella A, Pristipino C, Cianfrocca C et al (2013) One-year results of the randomized, controlled, short-term psychotherapy in acute myocardial infarction (STEP-IN-AMI) trial. Int J Cardiol 170:132–139CrossRef
Roose SP, Dalack GW, Glassman AH et al (1991) Cardiovascular effects of bupropion in depressed patients with heart disease. Am J Psychiatry 148:512–516CrossRef
Roose SP, Laghrissi-Thode F, Kennedy JS et al (1998) Comparison of paroxetine and nortriptyline in depressed patients with ischemic heart disease. JAMA 279:287–291CrossRef
Rosson S, Monaco F, Miola A, et al. (2021) Longitudinal course of depressive, anxiety, and posttraumatic stress disorder symptoms after heart surgery: A meta-analysis of 94 studies. Psychosom Med 83:85–89
Rossom RC, Solberg LI, Magnan S et al (2017) Impact of a national collaborative care initiative for patients with depression and diabetes or cardiovascular disease. Gen Hosp Psychiatry 44:77–85CrossRef
Rosson S, Monaco F, Miola A et al (2021) Longitudinal course of depressive, anxiety, and posttraumatic stress disorder symptoms after heart surgery: a meta-analysis of 94 studies. Psychosom Med 83:85–93CrossRef
Roth GA, Johnson C, Abajobir A et al (2017) Global, regional, and national burden of cardiovascular diseases for 10 causes, 1990 to 2015. J Am Coll Cardiol 70(1):1–25CrossRef
Rothenhäusler HB (2010) The effects of cardiac surgical procedures on health-related quality of life, cognitive performance, and emotional status outcomes: a prospective 6-month follow-up study. Psychiatr Danubina 22:135–136
Rothenhäusler HB, Stepan A, Hetterle R, Trantina-Yates A (2010) Prospektive Untersuchung zu den Auswirkungen aortokoronarer Bypassoperationen auf die gesundheitsbezogene Lebensqualität, kognitive Performanz und emotionale Befindlichkeit im 6-Monats-Verlauf. Fortschr Neurol Psychiatr 78:343–354CrossRef
Roy SS, Foraker RE, Girton RA, Mansfield AL (2015) Posttraumatic stress disorder and incident heart failure among a community—ased sample of US-veterans. Am J Pub Health 105:757–763CrossRef
Rozanski A, Cohen R (2017) From vitality to vital exhaustion and other states of “tense tiredness”: a new biopsychosocial risk domain. Psychosom Med 79:256–259CrossRef
Ruddox V, Sandven I, Munkhaugen J, et al. Atrial fibrillation and the risk for myocardial infarction, all-cause mortality and heart failure: A systematic review and meta-analysis. Eur J Prev Cardiol 24:1555–1566
Rugulies R (2002) Depression as a predictor for coronary heart disease: a review and meta-analysis. Am J Prev Med 23:51–61CrossRef
Rutledge T, Linke SE, Krantz DS et al (2009) Comorbid depression and anxiety symptoms as predictors of cardiovascular events: results from the NHLBI-sponsored Women’s Ischemia Syndrome Evaluation (WISE) study. Psychosom Med 71:958–964CrossRef
Rutledge T, Reis VA, Linke SE, Greenberg BH, Mills PJ (2006) Depression in heart failure a meta-analytic review of prevalence, intervention effects, and associations with clinical outcomes. J Am Coll Cardiol 48:1527–1537CrossRef
Rutledge T, Redwine LS, Linke SE, Mills PJ (2013) A meta-analysis of mental health treatments and cardiac rehabilitation for improving clinical outcomes and depression among patients with coronary heart disease. Psychosom Med 75:335–349CrossRef
Safi-Aghdam H, Shafie M, Khoshdel A et al (2019) Long-term effects of chemical warfare on post-traumatic stress disorder, depression, and chronic medical conditions in veterans. Community Ment Health J 55:493–496CrossRef
Sahoo S, Padhy SK, Padhee B et al (2018) Role of personality in cardiovascular diseases: an issue that needs to be focused too! Indian Heart J 70(suppl 3):S471–S477CrossRef
Salmoirago-Blotcher E, Rosman L, Wittstein IS et al (2016) Psychiatric history, post-discharge distress, and personality characteristics among incident female cases of takotsubo cardiomyopathy: a case-control study. Heart Lung 45:503–509CrossRef
Samartzis L, Dimopoulos S, Tziongourou M et al (2013) SSRIs versus exercise training for depression in chronic heart failure: a meta-analysis of randomized controlled trials. Int J Cardiol 168(5):4956–4958CrossRef
Sandström YK, Ljunggren G, Wändell P et al (2016) Psychiatric comorbidities in patients with hypertension–a study of registered diagnoses 2009–2013 in the total population in Stockholm County, Sweden. J Hypertens 34:414–420CrossRef
Schelling G, Richter M, Roozendaal B et al (2003) Exposure to high stress in the intensive care unit may have negative effects on health-related quality-of-life outcomes after cardiac surgery. Crit Care Med 31:1971–1980CrossRef
Schnabel RB, Hasenfuß G, Buchmann S et al (2021) Heart and brain interactions: pathophysiology and management of cardio-psycho-neurological disorders. Herz 46:138–149CrossRef
Schneider B, Athanasiadis A, Stollberger C et al (2013) Gender differences in the manifestation of takotsubo cardiomyopathy. Int J Cardiol 166:584–588CrossRef
Schnurr PP (2015) Understanding pathways from traumatic exposure to physical health. In: Schnyder U, Cloitre M (Hrsg) Evidence based treatments for trauma- related psychological disorders. A practical guide for clinicians. Springer, Switzerland, S 87–103
Schultz WM, Kelli HM, Lisko JC et al (2018) Socioeconomic status and cardiovascular outcomes: challenges and interventions. Circulation 137:2166–2178CrossRef
Sciomer S, Moscucci F, Dessalvi CC et al (2018) Gender differences in cardiology: is it time for new guidelines? J Cardiovasc Med 19:685–688CrossRef
Scott KM, de Jonge P, Alonso J et al (2013) Associations between DSM-IV mental disorders and subsequent heart disease onset: beyond depression. Int J Cardiol 168:5293–5299CrossRef
Segman RH, Stein MB (2015) C-reactive protein: a stress diathesis marker at the crossroads of maladaptive behavioral and cardiometabolic sequelae. Am J Psychiatry 172:307–309CrossRef
Seldenrijk A, Vogelzangs N, Batelaan NM et al (2015) Depression, anxiety and 6-year risk of cardiovascular disease. J Psychosom Res 78:123–129CrossRef
Shah AJ, Veledar E, Hong Y, Bremner JD, Vaccarino V (2011) Depression and history of attempted suicide as risk factors for heart disease mortality in young individuals. Arch Gen Psychiatry 68:1135–1142CrossRef
Shah P, Catmur C, Bird G (2017) From heart to mind: linking interoception, emotion, and theory of mind. Cortex 93:220–223CrossRef
Shah AJ, Wittbrodt MT, Bremner JD, Vaccarino V (2022) Cardiovascular pathophysiology from the cardioneural perspective and its clinical applications. Trends Cardiovasc Med 32:172–177CrossRef
Shaprio PA (2017) Cardiovascular disorders. In: Levenson JL, Ferrando SJ (Hrsg) Clinical manual of psychopharmacology in the medically ill, 2. Aufl. American pychiatric Association Publishuing, Arlington, S 233–270
Shapiro PA (2019) Heart disease. In: Levenson JL (Hrsg) The American psychiatric association publishing textbook of psychosomatic medicine and consultation-liaison psychiatry, 3. Aufl. American Psychiatric Association Publishing, Washington, DC, S 465–507
Sharkey SW (2016) A clinical perspective of the Takotsubo syndrome. Heart Fail Clin 12:507–520CrossRef
Shay M, MacKinnon AL, Metcalfe A et al (2020) Depressed mood and anxiety as risk factors for hypertensive disorders of pregnancy: a systematic review and meta-analysis. Psychol Med 50:2128–2140CrossRef
Shemesh E, Annunziato RA, Weatherley BD et al (2011) A randomized controlled trial of the safety and promise of cognitive-behavioral therapy using imaginal exposure in patients with posttraumatic stress disorder resulting from cardiovascular illness. J Clin Psychiatry 72:168–174CrossRef
Sherwood A, Blumenthal JA, Smith PJ et al (2016) Effects of exercise and sertraline on measures of coronary heart disease risk in patients with major depression: results from the SMILE-II randomized clinical trial. Psychosom Med 78:602–609CrossRef
Shi Y, Lan J (2021) Effect of stress management training in cardiac rehabilitation among coronary artery disease: a systematic review and meta-analysis. Rev Cardiovasc Med 22:1491–1501CrossRef
Shi W, Ghisi GLM, Zhang L et al (2022) A systematic review, meta-analysis, and meta-regression of patient education for secondary prevention in patients with coronary heart disease: impact on psychological outcomes. Eur J Cardiovasc Nurs zvac001. https://​doi.​org/​10.​1093/​eurjcn/​zvac001 [Online ahead of print]
Siegrist J (2021) Psychosoziale Arbeitsbelastungen und Erkrankungsrisiken. Internist (Berlin) 62:893–898CrossRef
Silva LEV, Katayama PL (2017) Baroreflex-mediated sympatheic overactivation induced by mental stress in post-traumatic stress disorder depends on the type of stressor. J Physiol 595:5757–5758CrossRef
Singh K, Carson K, Usmani Z et al (2014) Systematic review and meta-analysis of incidence and correlates of recurrence of Takotsubo cardiomyopathy. Int J Cardiol 174:696–701CrossRef
Singh-Manoux A, Shipley MJ, Bell JA et al (2017) Association between inflammatory biomarkers and all-cause, cardiovascular and cancer-related mortality. CMAJ 189:E384–E390CrossRef
Smeijers L, Mostofsky E, Tofler GH et al (2017) Anxiety and anger immediately prior to myocardial infarction and long-term mortality: characteristics of high-risk patients. J Psychosom Res 93:19–27CrossRef
Šmigelskas K, Žemaitienė N, Julkunen J, Kauhanen J (2015) Type A behavior pattern is not a predictor of premature mortality. Int J Behav Med 22:161–169CrossRef
Smolderen KG, Spertus JA, Reid KJ, et al. (2012) Association of somatic and cognitive depressive symptoms and biomarkers in acute myocardial infarction: insights from the translational research investigating underlying disparities in acute myocardial infarction patients' health status registry. Biol Psychiatry 71: 22-29
Smolderen KG, Spertus JA, Reid KJ et al (2017) Association of somatic and cognitive depressive symptoms and biomarkers in acute myocardial infarction: insights from the translational research investigating underlying disparities in acute myocardial infarction patients’ health status registry. Biol Psychiatry 71:22–29CrossRef
Smoller JW (2016) The genetics of stress-related disorders: PTSD, depression, and anxiety disorders. Neuropsychopharmacology 41:297–319CrossRef
Smoller JW, Allison M, Cochrane BB et al (2009) Antidepressant use and risk of incident cardiovascular morbidity and mortality among postmenopausal women in the women’s health initiative study. Arch Intern Med 169:2128–2139CrossRef
Smoller JW, Pollack MH, Wassertheil-Smoller S et al (2007) Panic attacks and risk of incident cardiovascular events among postmenopausal women in the Women’s Health Initiative Observational Study. Arch Gen Psychiatry 64:1153–1160CrossRef
So HC, Sham PC (2017) Exploring the predictive power of polygenic scores derived from genome-wide association studies: a study of 10 complex traits. Bioinformatics 33:886–892
Soares-Filho GL, Arias-Carrión O, Santulli G et al (2014) Chest pain, panic disorder and coronary artery disease: a systematic review. CNS Neurol Disord Drug Targets 13:992–1001CrossRef
Sokoreli I, Pauws SC, Steyerberg EW et al (2018) Prognostic value of psychosocial factors for first and recurrent hospitalizations and mortality in heart failure patients: insights from the OPERA-HF study. Eur J Heart Fail 20:689–696CrossRef
Sotelo JL, Nemeroff CB (2017) Depression as a systemic disease. Pers Med Psychiatry 1:11–25
Spitzer C, Barnow S, Völzke H et al (2009) Trauma, posttraumatic stress disorder, and physical illness: findings from the general population. Psychosom Med 71:1012–1017CrossRef
Stenman M, Sartipy U (2019) Longitudinal changes in depression screening results in cardiac surgery patients. J Thorac Dis 11:920–926CrossRef
Stewart JC, Perkins AJ, Callahan CM (2014) Effect of collaborative care for depression on risk of cardiovascular events: data from the IMPACT randomized controlled trial. Psychosom Med 76:29–37CrossRef
Strawbridge R, Young AH, Cleare AJ (2017) Biomarkers for depression: recent insights, current challenges and future prospects. Neuropsychiatr Dis Treat 13:1245–1262CrossRef
Strik JJ, Honig A, Lousberg R et al (2000) Efficacy and safety of fluoxetine in the treatment of patients with major depression after first myocardial infarction: findings from a double-blind, placebocontrolled trial. Psychosom Med 62:783–789CrossRef
Su A, Al’Aref SJ, Beecy AN et al (2019) Clinical and socioeconomic predictors of heart failure readmissions: a review of contemporary literature. Mayo Clin Proc 94:1304–1320CrossRef
Sullivan M, LaCroix A, Russo J et al (1999) Depression in coronary heart disease. What is the appropriate diagnostic threshold? Psychosomatics 40:286–292CrossRef
Suls J (2013) Anger and the heart: perspectives on cardiac risk, mechanisms and interventions. Prog Cardiovasc Dis 55:538–547CrossRef
Sumner JA, Chen Q, Roberts AL et al (2017a) Cross-sectional and longitudinal associations of chronic posttraumatic stress disorder with inflammatory and endothelial function markers in women. Biol Psychiatry 82:875–884CrossRef
Sumner JA, Duncan LE, Wolf EJ et al (2017b) Posttraumatic stress disorder has genetic overlap with cardiometabolic traits. Psychol Med 47:2036–2039CrossRef
Sumner JA, Kubzansky LD, Elkind MSV et al (2015) Trauma exposure and posttraumatic stress disorder symptoms predict onset of cardiovascular events in women. Circulation 132:251–259CrossRef
Sunbul EA, Sunbul M, Gulec H (2017) The impact of major depression on heart rate variability and endothelial dysfunction in patients with stable coronary artery disease. Gen Hosp Psychiatry 44:4–9CrossRef
Sundbøll J, Schmidt M, Adelborg K et al (2017) Impact of pre-admission depression on mortality following myocardial infarction. Br J Psychiatry 210:356–361CrossRef
Suzuki T, Shiga T, Kuwahara K et al (2014) Impact of clustered depression and anxiety on mortality and rehospitalization in patients with heart failure. J Cardiol 64:456–462CrossRef
Székely A, Balog P, Benkö E et al (2007) Anxiety predicts mortality and morbidity after coronary artery and valve surgery–a 4-year follow-up study. Psychosom Med 69:625–631CrossRef
Takagi H, Ando T, Umemoto T et al (2017) Perioperative depression or anxiety and postoperative mortality in cardiac surgery: a systematic review and meta-analysis. Heart Vessels 32:1458–1468CrossRef
Targum SD, Nemeroff CB (2019) The effect of early life stress on adult psychiatric disorders. Innov Clin Neurosci 16:35–37
Tawakol A, Ishai A, Takx RA et al (2017) Relation between resting amygdalar activity and cardiovascular events: a longitudinal and cohort study. Lancet 389(10071):834–845CrossRef
Taylor CB, Youngblood ME, Catellier D et al (2005) Effects of antidepressant medication on morbidity and mortality in depressed patients after myocardial infarction. Arch Gen Psychiatry 62:792–798CrossRef
Taylor WD, Aizenstein HJ, Alexopoulos GS (2013) The vascular depression hypothesis: mechanisms linking vascular disease with depression. Mol Psychiatry 18:963–974CrossRef
Templin C, Ghadri JR, Diekmann J et al (2015) Clinical features and outcomes of takotsubo (stress) cardiomyopathy. N Engl J Med 373:929–938CrossRef
Teply RM, Packard KA, White ND et al (2016) Treatment of depression in patients with concomitant cardiac disease. Prog Cardiovasc Dis 58:514–528CrossRef
Thase ME, Larsen KG, Reines E, Kennedy SH (2013) The cardiovascular safety profile of escitalopram. Eur Neuropsychopharmacol 23:1391–1400CrossRef
Thayer RE (1991) The psychobiology of mind and arousal. Oxford University Press, Oxford
Thombre MK, Holzman C, Wasilevich E et al (2019) Pregnancy hypertension and its associations with pre-pregnancy depression, anxiety, antidepressants, and anxiolytics. Pregnancy Hypertens 16:67–74CrossRef
Thombre MK, Talge NM, Holzman C (2015) Association between pre-pregnancy depression/anxiety symptoms and hypertensive disorders of pregnancy. J Womens Health 24:228–236CrossRef
Thombs BD, Bass EB, Ford DE et al (2006) Prevalence of depression in survivors of acute myocardial infarction. J Gen Intern Med 21:30–38CrossRef
Thurston RC, Rewak M, Kubzansky LD (2013)An anxious heart: anxiety and the onset of cardiovascular diseases. Prog Cardiovasc Dis 55:524–537
Tiihonen J, Lönnqvist J, Wahlbeck K et al (2006) Antidepressants and the risk of suicide, attempted suicide, and overall mortality in a nationwide cohort. Arch Gen Psychiatry 63:1358–1367CrossRef
Tolmunen T, Heliste M, Lehto SM et al (2011) Stability of alexithymia in the general population: an 11-year follow-up. Compr Psychiatry 52:536–541CrossRef
Tran HV, Gore JM, Darling CE et al (2019) Clinically significant ventricular arrhythmias and progression of depression and anxiety following an acute coronary syndrome. J Psychosom Res 117:54–62CrossRef
Triposkiadis F, Xanthopoulos A, Parissis J et al (2022) Pathogenesis of chronic heart failure: cardiovascular aging, risk factors, comorbidities, and disease modifiers. Heart Fail Rev 27:337–344CrossRef
Tu RH, Zeng ZY, Zhong GQ et al (2014) Effects of exercise training on depression in patients with heart failure: a systematic review and meta-analysis of randomized controlled trials. Eur J Heart Fail 16:749–757CrossRef
Tulloch H, Greenman PS, Tassé V (2014) Post-traumatic stress disorder among cardiac patients: prevalence, risk factors, and considerations for assessment and treatment. Behav Sci 5:27–40CrossRef
Tully PJ, Baker RA (2012) Depression, anxiety, and cardiac morbidity outcomes after coronary artery bypass surgery: a contemporary and practical review. J Geriatr Cardiol 9:197–208CrossRef
Tully PJ, Baker RA, Knight J et al (2009) Neuropsychological function 5 years after cardiac surgery and the effect of psychological distress. Arch Clin Neuropsychol 24:741–751CrossRef
Tully PJ, Pedersen SS, Winefield HR et al (2011) Cardiac morbidity risk and depression and anxiety: a disorder, symptom and trait analysis among cardiac surgery patients. Psychol Health Med 16:333–345CrossRef
Tully PJ, Cosh SM, Baune BT (2013) A review of the affects of worry and generalized anxiety disorder upon cardiovascular health and coronary heart disease. Psychol Health Med 18:627–644CrossRef
Tully PJ, Cosh SM, Baumeister H (2014) The anxious heart in whose mind? A systematic review and meta-regression of factors associated with anxiety disorder diagnosis, treatment and morbidity risk in coronary heart disease. J Psychosom Res 77:439–448CrossRef
Tully PJ, Newland RF, Baker RA (2015a) Cardiovascular risk profile before coronary artery bypass graft surgery in relation to depression and anxiety disorders: an age and sex propensity matched study. Aust Crit Care 28:24–30CrossRef
Vaccarino V, Bremner JD (2017) Behavioral, emotional and neurobiological determinants of coronary heart disease risk in women. Neurosci Biobehav Rev 74:297–309CrossRef
Vaccarino V, Lampert R, Bremner JD et al (2008) Depressive symptoms and heart rate variability: evidence for a shared genetic substrate in a study of twins. Psychosom Med 70:628–636CrossRef
Vaccarino V, Goldberg J, Rooks C et al (2013) Post-traumatic stress disorder and incidence of coronary heart disease: a twin study. J Am Coll Cardiol 62:970–978CrossRef
Vaccarino V, Sullivan S, Hammadah M et al (2018) Mental stress-induced-myocardial ischemia in young patients with recent myocardial infarction: sex differences and mechanisms. Circulation 137:794–805CrossRef
Vaccarino V, Badimon L, Bremner JD et al (2020) Depression and coronary heart disease: 2018 ESC position paper of the working group of coronary pathophysiology and microcirculation developed under the auspices of the ESC Committee for Practice Guidelines. Eur Heart J 41:1687–1696CrossRef
Vaccarino V, Almuwaqqat Z, Kim JH et al (2021) Association of mental stress-induced myocardial ischemia with cardiovascular events in patients with coronary heart disease. JAMA 326:1818–1828CrossRef
Valtorta NK, Kanaan M, Gilbody S et al (2016) Loneliness and social isolation as risk factors for coronary heart disease and stroke: systematic review and meta-analysis of longitudinal observational studies. Heart 102:1009–1016CrossRef
van der Kooy K, van Hout H, Marwijk H et al (2007) Depression and the risk for cardiovascular diseases: systematic review and metaanalysis. Int J Geriatr Psychiatry 22:613–626CrossRef
van der Merwe C, Jahanshad N, Cheung JW et al (2019) Concordance of genetic variation that increases risk for anxiety disorders and posttraumatic stress disorders and that influences their underlying neurocircuitry. J Affect Disord 245:885–896CrossRef
van Melle JP, de Jonge P, Spijkerman TA et al (2011) Prognostic association of depression following myocardial infarction with mortality and cardiovascular events: a meta-analysis. Psychosom Med 66:814–822CrossRef
van Montfort E, Kupper N, Widdershoven J, Denollet J (2018) Person-centered analysis of psychological traits to explain heterogeneity in patient-reported outcomes of coronary artery disease—the THORESCI study. J Affect Disord 236:14–22CrossRef
Versteeg H, Timmermans I, Meine M et al (2017) Prevalence and risk markers of early psychological distress after ICD implantation in the European REMOTE-CIED study cohort. Int J Cardiol 240:208–213CrossRef
Vieweg WVR, Hasnain M, Mezuk B et al (2011) Depression, stress, and heart disease in earthquakes and takotsubo cardiomyopathy. Am J Med 124:900–907CrossRef
Vilchinsky N, Ginzburg K, Fait K, Foa EB (2017) Cardiac-disease-induced PTSD (CDI-PTSD): a systematic review. Clin Psychol Rev 55:92–106CrossRef
Virtanen M, Jokela M, Madsen IE et al (2018) Long working hours and depressive symptoms: systematic review and meta-analysis of published studies and unpublished individual participant data. Scand J Work Environ Health 44:239–250CrossRef
Vogelzangs N, Beekman AT, Milaneschi Y et al (2010a) Urinary cortisol and six-year risk of all-cause and cardiovascular mortality. Clin Endocrinol Metab 95:4959–4964CrossRef
Vogelzangs N, Seldenrijk A, Beekman AT et al (2010b) Cardiovascular disease in persons with depressive and anxiety disorders. J Affect Disord 125:241–248CrossRef
von Känel R (2015) Acute mental stress and hemostasis: when physiology becomes vascular harm. Thromb Res 135(Suppl 1):S52–S55CrossRef
von Känel R, Barth J, Princip M et al (2018) Early psychological counseling for the prevention of posttraumatic stress induced by acute coronary syndrome: the MI-SPRINT randomized controlled trial. Psychother Psychosom 87:75–84CrossRef
von Känel R, Hari R, Schmid JP et al (2011) Non-fatal cardiovascular outcome in patients with posttraumatic stress symptoms caused by myocardial infarction. J Cardiol 58:61–68CrossRef
Vroege EM, Zuidersma M, de Jonge P (2012) Vital exhaustion and somatic depression: the same underlying construct in patients with myocardial infarction? Psychosom Med 74:446–451CrossRef
Wallenborn J, Angermann CE (2016) Depression und Herzinsuffizienz – doppeltes Risiko? Diagnostik, prognostische Bedeutung und Therapie einer unterschätzten Komorbidität. Herz 41:741–754CrossRef
Walters K, Rait G, Petersen I, Williams R, Nazareth I (2008) Panic disorder and risk of new onset coronary heart disease, acute myocardial infarction, and cardiac mortality: cohort study using the general practice research database. Eur Heart J 29:2981–2988CrossRef
Wändell P, Carlsson AC, Gasevic D et al (2016) Depression or anxiety and all-cause mortality in adults with atrial fibrillation–A cohort study in Swedish primary care. Ann Med 48:59–66CrossRef
Watkins LL, Blumenthal JA, Babyak MA et al (2010) Prospective association between phobic anxiety and cardiac mortality in individuals with coronary heart disease. Psychosom Med 72:664–671CrossRef
Weeke P, Jensen A, Folke F et al (2012) Antidepressant use and risk of out-of-hospital cardiac arrest: a nationwide case-time-control study. Clin Pharmacol Ther 92:72–79CrossRef
Wentworth BA, Stein MB, Redwine LS et al (2013) Post-traumatic stress disorder: a fast track to premature cardiovascular disease? Cardiol Rev 21:16–22CrossRef
Wernicke J, Lledó A, Raskin J, Kajdasz DK, Wang F (2007) An evaluation of the cardiovascular safety profile of duloxetine: findings from 42 placebo-controlled studies. Drug Saf 30:437–455CrossRef
Westhoff-Bleck M, Briest J, Fraccarollo D et al (2016) Mental disorders in adults with congenital heart disease: unmet needs and impact on quality of life. J Affect Disord 204:180–186CrossRef
Whang W, Kubzansky LD, Kawachi I et al (2009) Depression and risk of sudden cardiac death and coronary heart disease in women. Results from the Nurses’ health study. J Am Coll Cardiol 53:950–958CrossRef
White JR, Chang CC, So-Armah KA et al (2015) Depression and human immunodeficiency virus infection are risk factors for incident heart failure among veterans: veterans aging cohort study. Circulation 132:1630–1638CrossRef
Whitehead D, Perkins-Porras L, Strike PC, Steptoe A (2006) Posttraumatic stress disorder in cardiac patients: predicting vulnerability from emotional responses during admission for acute coronary syndromes. Heart 92:1225–1229CrossRef
Whooley MA, Wong JM (2013) Depression and cardiovascular disorders. Annu Rev Clin Psychol 9:327–354CrossRef
Wilbert-Lampen U, Leistner D, Greven S et al (2008) Cardiovascular events during World Cup soccer. N Engl J Med 358:475–483CrossRef
Williams JB, Alexander KP, Morin JF et al (2013) Preoperative anxiety as a predictor of mortality and major morbidity in patients aged >70 years undergoing cardiac surgery. Am J Cardiol 111:137–142CrossRef
Wittchen HU, Jacobi F, Rehm J et al (2011) The size and burden of mental disorders and other disorders of the brain in Europe 2010. Eur Neuropsychopharmacology 21:655–679CrossRef
Wium-Andersen MK, Wium-Andersen IK, Prescott EIB et al (2020) An attempt to explain the bidirectional association between ischaemic heart disease, stroke and depression: a cohort and meta-analytic approach. Br J Psychiatry 217:434–441CrossRef
Wong MF (2017) Factors associated with anxiety and depression among patients with implantable cardioverter defibrillator. J Clin Nurs 26:1328–1337CrossRef
Wong BC, Chau CK, Ao FK et al (2019a) Differential associations of depression-related phenotypes with cardiometabolic risks: polygenic analyses and exploring shared genetic variants and pathways. Depress Anxiety 36:330–344CrossRef
Wong CX, Brown A, Lau DH et al (2019b) Epidemiology of sudden cardiac death: global and regional perspectives. Heart Lung Circ 28:6–14CrossRef
Wu VC, Chang SH, Kuo CF et al (2018) Suicide death rates in patients with cardiovascular diseases – a 15-year nationwide cohort study in Taiwan. J Affect Disord 238:187–193CrossRef
Wulsin LR, Singal BM (2003) Do depressive symptoms increase the risk for the onset of coronary disease? A systematic quantitative review. Psychosom Med 65:201–210CrossRef
Wulsin L, Herman J, Thayer JF (2018) Stress, autonomic imbalance, and the prediction of metabolic risk: a model and proposal for research. Neurosci Biobehav Rev 86:12–20CrossRef
Wyman L, Crum RM, Celentano D (2012) Depressed mood and cause-specific mortality: a 40-year general community assessment. Ann Epidemiol 22:638–643CrossRef
Xia N, Li H (2018) Loneliness, social isolation, and cardiovascular health. Antioxid Redox Signal 28:837–851CrossRef
Yaqub Y, Jenkins LA, Nugent KM, Chokesuwattanaskul W (2009) Postpartum depression and apical ballooning syndrome (takotsubo syndrome). J Obstet Gynaecol Can 31:736–739CrossRef
Yu HY, Park YS, Son YJ (2017) Combined effect of left ventricular ejection fraction and post-cardiac depressive symptoms on major adverse cardiac events after successful primary percutaneous coronary intervention: a 12-month follow-up. Eur J Cardiovasc Nurs 16:37–45CrossRef
Yui K, Imataka G, Nakamura H, Ohara N, Naito Y (2015) Eicosanoids derived from arachidonic acid and their family prostaglandins and cyclooxygenase in psychiatric disorders. Curr Neuropharmacol 13:776–785CrossRef
Yusuf S, Hawken S, Ounpuu S et al INTERHEART Study Investigators (2004) Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet 364(9438):937–952
Zhang L, Piña IL (2019) Stress-induced cardiomyopathy. Heart Failure Clin 15:41–53CrossRef
Zhang Y, Chen Y, Maa K (2018) Depression and cardiovascular disease in elderly: current understanding. J Clin Neurosci 47:1–5CrossRef
Zhang Y, Liang Y, Huang H, Xu Y (2021) Systematic review and meta-analysis of psychological intervention on patients with coronary heart disease. Ann Palliat Med 10:8848–8857CrossRef
Zhu DR, Julian J, Lee SJA et al (2018) Patterns of peritraumatic threat perceptions in patients evaluated for suspected acute coronary syndrome according to prior and current posttraumatic stress symptoms. Gen Hosp Psychiatry 53:119–124CrossRef
Zitron E, Kiesecker C, Scholz E, Luck S et al (2004) Inhibition of cardiac HERG potassium channels by the atypical antidepressant trazodone. Naunyn Schmiedebergs Arch Pharmacol 370:146–156CrossRef
Zou H, Cao X, Chair SY (2021) A systematic review and meta-analysis of mindfulness-based interventions for patients with coronary heart disease. J Adv Nurs 77:2197–2213CrossRef
Zuidersma M, Ormel J, Conradi HJ, de Jonge P (2012) An increase in depressive symptoms after myocardial infarction predicts new cardiac events irrespective of depressive symptoms before myocardial infarction. Psychol Med 42:683–693CrossRef
Zuidersma M, Conradi HJ, van Melle JP et al (2013) Depression treatment after myocardial infarction and long-term risk of subsequent cardiovascular events and mortality: a randomized controlled trial. J Psychosom Res 74:25–30CrossRef
Zuzarte P, Duong A, Figueira ML et al (2018a) Current therapeutic approaches for targeting inflammation in depression and cardiovascular disease. Curr Drug Metab 19:674–687CrossRef
Zuzarte P, Scola G, Duong A et al (2018b) NT-proBNP is a potential mediator between reduced ejection fraction and depression in patients with heart failure. J Psychiatr Res 104:8–15CrossRef
Metadaten
Titel
Kardiovaskuläre Erkrankungen
verfasst von
Hans-Peter Kapfhammer
Copyright-Jahr
2022
Verlag
Springer Berlin Heidelberg
Buch
Depression, Angst, traumatischer Stress und internistische Erkrankungen

Print ISBN: 978-3-662-65872-7

Electronic ISBN: 978-3-662-65873-4

Copyright-Jahr: 2022

DOI
https://doi.org/10.1007/978-3-662-65873-4_2

Neu im Fachgebiet Psychiatrie

ADHS-Medikation erhöht das kardiovaskuläre Risiko

16.05.2024 Herzinsuffizienz Nachrichten

Erwachsene, die Medikamente gegen das Aufmerksamkeitsdefizit-Hyperaktivitätssyndrom einnehmen, laufen offenbar erhöhte Gefahr, an Herzschwäche zu erkranken oder einen Schlaganfall zu erleiden. Es scheint eine Dosis-Wirkungs-Beziehung zu bestehen.

Typ-2-Diabetes und Depression folgen oft aufeinander

14.05.2024 Typ-2-Diabetes Nachrichten

Menschen mit Typ-2-Diabetes sind überdurchschnittlich gefährdet, in den nächsten Jahren auch noch eine Depression zu entwickeln – und umgekehrt. Besonders ausgeprägt ist die Wechselbeziehung laut GKV-Daten bei jüngeren Erwachsenen.

Darf man die Behandlung eines Neonazis ablehnen?

08.05.2024 Gesellschaft Nachrichten

In einer Leseranfrage in der Zeitschrift Journal of the American Academy of Dermatology möchte ein anonymer Dermatologe bzw. eine anonyme Dermatologin wissen, ob er oder sie einen Patienten behandeln muss, der eine rassistische Tätowierung trägt.

Spezielles Sportprogramm bei einer Reihe von psychischen Erkrankungen effektiv

08.05.2024 Psychotherapie Nachrichten

Sportliche Betätigung hilft nicht nur bei Depression, sondern auch in Gruppen von Patientinnen und Patienten mit unterschiedlichen psychischen Erkrankungen, wie Insomnie, Panikattacken, Agoraphobie und posttraumatischem Belastungssyndrom. Sie alle profitieren längerfristig.

Bildnachweise